{"taxa": [{"scientific_name": "suregada adenophora baill", "compounds": ["\u03b1-homonojirimycin"], "accepted_name": "Suregada adenophora", "accepted_species": "Suregada adenophora", "accepted_genus": "Suregada", "inchi_keys": {"\u03b1-homonojirimycin": "CLVUFWXGNIFGNC-QTSLKERKSA-N"}, "inchi_key_simps": {"\u03b1-homonojirimycin": "CLVUFWXGNIFGNC"}}, {"scientific_name": "suregada angustifolia (m\u00fcll.arg.) airy shaw", "compounds": ["epi-friedelinol", "friedelin", "\u03b2-sitosterol-3-\u03b2-d-glucopyranoside", "baurenol", "\u03b2-sitosterol", "\u03b1-amyrin", "n-octacosanol"], "accepted_name": "Suregada lanceolata", "accepted_species": "Suregada lanceolata", "accepted_genus": "Suregada", "inchi_keys": {"epi-friedelinol": "XCDQFROEGGNAER-VYFOYESCSA-N", "friedelin": "OFMXGFHWLZPCFL-SVRPQWSVSA-N", "baurenol": "TZVDWGXUGGUMCE-JVHXOXOBSA-N", "\u03b2-sitosterol": "KZJWDPNRJALLNS-VJSFXXLFSA-N", "\u03b1-amyrin": "FSLPMRQHCOLESF-SFMCKYFRSA-N", "n-octacosanol": "CNNRPFQICPFDPO-UHFFFAOYSA-N"}, "inchi_key_simps": {"epi-friedelinol": "XCDQFROEGGNAER", "friedelin": "OFMXGFHWLZPCFL", "baurenol": "TZVDWGXUGGUMCE", "\u03b2-sitosterol": "KZJWDPNRJALLNS", "\u03b1-amyrin": "FSLPMRQHCOLESF", "n-octacosanol": "CNNRPFQICPFDPO"}}, {"scientific_name": "suregada boiviniana baill", "compounds": null, "accepted_name": "Suregada boiviniana", "accepted_species": "Suregada boiviniana", "accepted_genus": "Suregada", "inchi_keys": {}, "inchi_key_simps": {}}, {"scientific_name": "suregada decidua radcl.-sm", "compounds": null, "accepted_name": "Suregada decidua", "accepted_species": "Suregada decidua", "accepted_genus": "Suregada", "inchi_keys": {}, "inchi_key_simps": {}}, {"scientific_name": "suregada lanceolata (willd.) kuntze", "compounds": null, "accepted_name": "Suregada lanceolata", "accepted_species": "Suregada lanceolata", "accepted_genus": "Suregada", "inchi_keys": {}, "inchi_key_simps": {}}, {"scientific_name": "suregada lithoxyla (pax & k.hoffm.) croizat", "compounds": null, "accepted_name": "Suregada lithoxyla", "accepted_species": "Suregada lithoxyla", "accepted_genus": "Suregada", "inchi_keys": {}, "inchi_key_simps": {}}, {"scientific_name": "suregada multiflora (a. juss.) baill", "compounds": ["3\u03b2-hydroxy-1-one-8\u03b2,14\u03b2-epoxy-13,15-abiatene-16,12-olide", "gelomuloside a", "3\u03b2-acetoxy-1-one-8\u03b2,14\u03b2-epoxy-13,15-abiatene-16,12-olide", "suremulol b", "abbeokutone", "gelomuloside b", "gelomulide c", "suregadolide b", "gelomulide g", "pinnatin", "2-ene-1-one-8\u03b2,14\u03b2-epoxy-13,15-abiatene-16,12-olide", "suregadolide c", "luteolin-7,4\u2032-dimethyl ether 3\u2032-glucoside", "gelomulide f", "3\u03b2,6\u03b2-diacetoxy-1-one-8\u03b2,14\u03b2-epoxy-13,15-abiatene-16,12-olide", "suregadolide d", "baurenol", "3\u03b2-hydroxy-8,14\u03b2:11,12\u03b1-diepoxy-13(15)-abietane-16,12-olide", "3\u03b2-acetoxy-8\u03b2,14\u03b1-dihydroxy-13,15-abiatene-16,12-olide", "gelomulide d", "helioscopinolide a", "dimethoxy kanugin", "ent-3-oxo-16-kauren-15\u03b2,18-diol", "helioscopinolide c", "gelomulide j", "helioscopinolide i", "syringaresinol", "gelomulide e", "gelomulide i", "gelomulide b", "7-multifloren-3\u03b1-ol", "3\u03b2-acetoxy-8\u03b2,14\u03b2-epoxy-13,15-abiatene-16,12-olide", "suregadolide a", "ent-16-kaurene-3\u03b2,15\u03b2-diol", "gelomulide a", "3\u03b2-acetoxy-8\u03b2,14\u03b1-dihydroxy-1-one-13,15-abiatene-16,12-olide", "6\u03b2-acetoxy-2-ene-1-one-8\u03b2,14\u03b2-epoxy-13,15-abiatene-16,12-olide", "6\u03b2-acetoxy-2-ene-8\u03b2,14\u03b1-dihydroxy-1-one-13,15-abiatene-16,12-olide", "kanugin", "gelomulide h", "pinoresinol", "7,4'-o-l-ramnopyranosyl (12)-d-glucopyranoside", "3\u03b2,6b-diacetoxy-8\u03b2,14\u03b2-epoxy-13,15-abiatene-16,12-olide", "suremulide a", "ent-16-kauren-3\u03b2,15\u03b2,18-triol", "bannaringaolide a", "suremulol a", "7-multifloren-3\u03b2-ol"], "accepted_name": "Suregada multiflora", "accepted_species": "Suregada multiflora", "accepted_genus": "Suregada", "inchi_keys": {"gelomuloside a": "HFNIATQIKQCDMZ-VHVDPMTKSA-N", "abbeokutone": "MPDUJZZNNBJFAB-OMTDFQDJSA-N", "gelomuloside b": "FLNGHKQBVLFAGJ-IIYXSDHHSA-N", "suregadolide b": "XLQPKIPZCCDQMM-GRLXCJONSA-N", "gelomulide g": "KTOGURYEQRFUME-SKOXMUMBSA-N", "pinnatin": "QNWOJWLIFBMWKQ-UHFFFAOYSA-N", "suregadolide c": "OGQHKGNLUBCRDN-AXZPYZERSA-N", "suregadolide d": "OGQHKGNLUBCRDN-QKCUJYLTSA-N", "baurenol": "TZVDWGXUGGUMCE-JVHXOXOBSA-N", "helioscopinolide a": "KZIADLALQLRZIQ-RXFYRGCNSA-N", "syringaresinol": "KOWMJRJXZMEZLD-UHFFFAOYSA-N", "gelomulide b": "WDPSZJMRQVJIBN-CLAXDQGUSA-N", "suregadolide a": "ZZRMOWIKHWOSFN-LAFNOEKWSA-N", "gelomulide a": "FEAJKDLCGUYWFP-YNWCVRRFSA-N", "kanugin": "HZHNYQLMLQAKSH-UHFFFAOYSA-N", "pinoresinol": "HGXBRUKMWQGOIE-AFHBHXEDSA-N"}, "inchi_key_simps": {"gelomuloside a": "HFNIATQIKQCDMZ", "abbeokutone": "MPDUJZZNNBJFAB", "gelomuloside b": "FLNGHKQBVLFAGJ", "suregadolide b": "XLQPKIPZCCDQMM", "gelomulide g": "KTOGURYEQRFUME", "pinnatin": "QNWOJWLIFBMWKQ", "suregadolide c": "OGQHKGNLUBCRDN", "suregadolide d": "OGQHKGNLUBCRDN", "baurenol": "TZVDWGXUGGUMCE", "helioscopinolide a": "KZIADLALQLRZIQ", "syringaresinol": "KOWMJRJXZMEZLD", "gelomulide b": "WDPSZJMRQVJIBN", "suregadolide a": "ZZRMOWIKHWOSFN", "gelomulide a": "FEAJKDLCGUYWFP", "kanugin": "HZHNYQLMLQAKSH", "pinoresinol": "HGXBRUKMWQGOIE"}}, {"scientific_name": "suregada procera (prain) croizat", "compounds": null, "accepted_name": "Suregada procera", "accepted_species": "Suregada procera", "accepted_genus": "Suregada", "inchi_keys": {}, "inchi_key_simps": {}}, {"scientific_name": "suregada zanzibariensis baill", "compounds": ["zanzibariolide b", "simiarenol", "zanzibariolide a", "jolkinolide b", "\u03b1-amyrin", "mangiolide"], "accepted_name": "Suregada zanzibariensis", "accepted_species": "Suregada zanzibariensis", "accepted_genus": "Suregada", "inchi_keys": {"simiarenol": "XVXPXUMUGATHPD-JMJRLLIOSA-N", "jolkinolide b": "SOVOCMGDFRGRKF-MCDHERAVSA-N", "\u03b1-amyrin": "FSLPMRQHCOLESF-SFMCKYFRSA-N"}, "inchi_key_simps": {"simiarenol": "XVXPXUMUGATHPD", "jolkinolide b": "SOVOCMGDFRGRKF", "\u03b1-amyrin": "FSLPMRQHCOLESF"}}, {"scientific_name": "suregada aequoreum hance", "compounds": ["gelumolide m", "gelumolide t", "gelumolide v", "gelumolide r", "gelumolide u", "gelumolide o", "6\u03b2-acetoxy-1-one-8\u03b2,14-\u03b1-dihydroxy-ent-abieta2(3),13(15)-diene,12-olide", "gelumolide s", "gelumolide l", "gelumolide k", "gelumolide p", "gelumolide w", "gelumolide x", "gelumolide q", "gelumolide n"], "accepted_name": "Suregada", "accepted_species": null, "accepted_genus": null, "inchi_keys": {}, "inchi_key_simps": {}}, {"scientific_name": "suregada glomerulata (blume) baill", "compounds": ["6-c-(8-hydroxyoctyl)-2,5-dideoxy-2,5-imino-d-galactitol", "isoleucine", "3,4,18b-cyclopropa-ent-abieta-8(14),13(15)-dien-16,12-olide", "7\u03b2,8\u03b1\u03b2-dihydroxy-12-oxo-ent-abietan-16,14-olide", "uridine", "6-c-(8-hydroxyoctyl)-dmdp", "13\u03b1-hydroxy-14\u03b1,16-epoxy-ent-abieta-7-en-3-one", "7-oxo-ent-abieta-5,8(14),13(15)-trien-16,12-olide", "2\u03b1-carboxymethyl-5\u03b1-dimethylamino-4\u03b1-hydroxy-tetrahydrpyran", "7\u03b2-hydroxy-ent-abieta-8(14),13(15)-dien-16,12-olide", "7\u03b2,17-dihydroxy-ent-abieta-8(14),13(15)-dien-16,12-olide", "ent-kaurane-3\u03b2,16\u03b2,17-triol", "euphoranginol b", "6-c-butyl-4-deoxy-dmdp", "17-hydroxy-ent-pimara-8(14),15-dien-3-one", "2,5-imino-2,4,5,6-tetradeoxy-d-gulo-heptitol", "3-oxo-jolkinolide b", "3-oxo-8\u03b2,14\u03b2-epoxy-ent-abieta-11,13(15)-dien-16,12-olide", "leucine", "(r)-carnitine", "lysine", "methyl 12-hydroxy-3-oxo-ent-abieta-8,11,13-trien-17-oate", "3\u03b1,7\u03b2-dihydroxy-ent-abieta-8(14),13(15)-dien-16,12-olide", "uracil", "guanosine", "5\u03b2-carboxymethyl-3\u03b1-hydroxy-2\u03b2-hydroxymethyl-1,1-dimethylpryrrolidine", "3,4,18\u03b2-cyclopropa-7\u03b2,17-dihydroxy-ent-abieta-8(14),13(15)-dien-16,12-olide", "5\u03b2-carboxymethyl-3\u03b1-hydroxy-2\u03b2-hydroxymethyl-1-methylpryrrolidine", "2,5-imino-2,4,5-trideoxy-d-gulo-heptitol", "7-deoxy-homodmdp", "6-c-butyl-dmdp", "6-deoxy-homodmdp", "3h-imidazo [4,5-c]pyridine", "\u03b3-aminobutyric acid", "proline", "corymbol", "2,5-imino-2,4,5-trideoxy-d-manno-heptitol", "alanine", "1\u03b1,16\u03b1,17-trihydroxy-ent-kaurane", "2,5-imino-2,5,6-trideoxy-d-gulo-heptitol", "glutamic acid"], "accepted_name": "Suregada glomerulata", "accepted_species": "Suregada glomerulata", "accepted_genus": "Suregada", "inchi_keys": {"isoleucine": "AGPKZVBTJJNPAG-WHFBIAKZSA-N", "uridine": "DRTQHJPVMGBUCF-XVFCMESISA-N", "leucine": "ROHFNLRQFUQHCH-YFKPBYRVSA-N", "(r)-carnitine": "PHIQHXFUZVPYII-ZCFIWIBFSA-N", "lysine": "KDXKERNSBIXSRK-YFKPBYRVSA-N", "uracil": "ISAKRJDGNUQOIC-UHFFFAOYSA-N", "guanosine": "NYHBQMYGNKIUIF-UUOKFMHZSA-N", "7-deoxy-homodmdp": "GBQAQDYHLUTAGE-CQOGJGKDSA-N", "3h-imidazo [4,5-c]pyridine": "UBOOKRVGOBKDMM-UHFFFAOYSA-N", "\u03b3-aminobutyric acid": "BTCSSZJGUNDROE-UHFFFAOYSA-N", "proline": "ONIBWKKTOPOVIA-BYPYZUCNSA-N", "corymbol": "NRRPVTKXJHEKLP-UHFFFAOYSA-N", "alanine": "QNAYBMKLOCPYGJ-REOHCLBHSA-N", "2,5-imino-2,5,6-trideoxy-d-gulo-heptitol": "AGFACLQFIYFFOI-BWBBJGPYSA-N", "glutamic acid": "WHUUTDBJXJRKMK-VKHMYHEASA-N"}, "inchi_key_simps": {"isoleucine": "AGPKZVBTJJNPAG", "uridine": "DRTQHJPVMGBUCF", "leucine": "ROHFNLRQFUQHCH", "(r)-carnitine": "PHIQHXFUZVPYII", "lysine": "KDXKERNSBIXSRK", "uracil": "ISAKRJDGNUQOIC", "guanosine": "NYHBQMYGNKIUIF", "7-deoxy-homodmdp": "GBQAQDYHLUTAGE", "3h-imidazo [4,5-c]pyridine": "UBOOKRVGOBKDMM", "\u03b3-aminobutyric acid": "BTCSSZJGUNDROE", "proline": "ONIBWKKTOPOVIA", "corymbol": "NRRPVTKXJHEKLP", "alanine": "QNAYBMKLOCPYGJ", "2,5-imino-2,5,6-trideoxy-d-gulo-heptitol": "AGFACLQFIYFFOI", "glutamic acid": "WHUUTDBJXJRKMK"}}, {"scientific_name": "suregada gaultheriifolia radcl.-sm", "compounds": ["\u03b1-homonojirimycin"], "accepted_name": "Suregada gaultheriifolia", "accepted_species": "Suregada gaultheriifolia", "accepted_genus": "Suregada", "inchi_keys": {"\u03b1-homonojirimycin": "CLVUFWXGNIFGNC-QTSLKERKSA-N"}, "inchi_key_simps": {"\u03b1-homonojirimycin": "CLVUFWXGNIFGNC"}}], "text": "Citation: Mangisa, M.; Kemboi, D.;Fouche, G.; Nthambeleni, R.; Langat,M.K.; Tarirai, C.; Cheek, M.; Gonyela,O.; Tembu, V.J. Ethnomedicinal Uses,Phytochemistry and PharmacologicalProperties of Suregada Genus: AReview. Pharmaceuticals 2023, 16,1390. https://doi.org/10.3390/ph16101390Academic Editors: Isabel Ribeiro andNoelia DuarteReceived: 6 September 2023Revised: 25 September 2023Accepted: 27 September 2023Published: 30 September 2023Copyright: \u00a9 2023 by the authors.Licensee MDPI, Basel, Switzerland.This article is an open access articledistributed under the terms andconditions of the Creative CommonsAttribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).pharmaceuticalsReviewEthnomedicinal Uses, Phytochemistry and PharmacologicalProperties of Suregada Genus: A ReviewMandisa Mangisa 1, Douglas Kemboi 1,2,* , Gerda Fouche 3 , Rudzani Nthambeleni 4,Moses Kiprotich Langat 5 , Clemence Tarirai 6 , Martin Cheek 5, Odwa Gonyela 1and Vuyelwa Jacqueline Tembu 11 Department of Chemistry, Tshwane University of Technology, Private Bag X680, Pretoria 0001, South Africa;mangisam@tut.ac.za (M.M.); gonyelao@tut.ac.za (O.G.); tembuvj@tut.ac.za (V.J.T.)2 Department of Chemistry, University of Kabianga, Kericho 2030, Kenya3 Department of Chemistry, University of Pretoria, Private Bag X20, Pretoria 0001, South Africa;gerda.fouche@up.ac.za4 Biosciences, Council for Scientific and Industrial Research, Pretoria 0001, South Africa;nthambelenirudzani@gmail.com5 Science Department, Royal Botanic Gardens, Kew TW9 3DS, UK; m.langat@kew.org (M.K.L.);m.cheek@kew.org (M.C.)6 Department of Pharmaceutical Sciences, Tshwane University of Technology, Private Bag X680,Pretoria 0001, South Africa; tariraic@tut.ac.za* Correspondence: kemboidouglas01@gmail.comAbstract: Plants of the Suregada Roxb. ex Rottler (formerly Gelonium Roxb. ex Willd) are utilized totreat various ailments, namely, hepatic, gum diseases, pyrexia, eczema, and venereal diseases. Thisreview links the reported compounds to ethnomedicinal uses through pharmacological activities.The compounds possess anticancer, anti-allergic, antibacterial, anti-inflammatory, antioxidant, andanti-HIV properties. From the previous reports, 32 known species of the Suregada genus have beeninvestigated morphologically, and nine were investigated for their phytochemistry and pharmacology.Phytochemistry, ethnomedicinal, and pharmacological uses of the other 23 Suregada species are notknown and/or not reported. In this review, abietane diterpenoids are the main compounds expressedby the Suregada, accounting for 71 of the 114 reported compounds. Ten triterpenoids and sterols, onealiphatic, two lignans, five flavonoids, and twenty-one nitrogen-containing compounds have beenreported from the genus.Keywords: Euphorbiaceae; Suregada; phytochemistry; ethnomedicine; pharmacological uses1. IntroductionSuregada Roxb. ex Rottler (formerly Gelonium Roxb. ex Willd.) species are shrubs orsmall trees occurring in the forest, deciduous forest, or thicket with 32 accepted species,extending from Africa and Madagascar through India to southern New Guinea, China,Philippines, and northern Australia [1].Based on morphology, Suregada was placed in Euphorbiaceae-Crotonoideae in the tribeGelonieae with the monotypic Cladogelonium Leandri of Madagascar by Radcliffe-Smith ingenera Euphorbiacearum [2,3]. Wurdack et al. stated that the relationship between these twogenera was endorsed in a molecular phylogenetic study and was sister to the main clade ofCrotonoid genera [4].The genus Suregada is highly distinctive and cannot be confused with any other genusof tree or shrub in Sub-Saharan Africa. The combination of translucent gland dots in theleaves, leaf-opposed fasciculate or glomerulate inflorescences, and the node encircled bystipules (or stipular scars) separates it not only from all other genera in Euphorbiaceae butfrom all other genera with alternate simple leaves [2,3]. Suregada is best recognized by itsPharmaceuticals 2023, 16, 1390. https://doi.org/10.3390/ph16101390 https://www.mdpi.com/journal/pharmaceuticalsPharmaceuticals 2023, 16, 1390 2 of 28leaf-opposed inflorescences; the whole plant is usually drying bright green and often hascharacteristic pustules within the leaf areoles [3].The African species were last reviewed by L\u00e9onard when publishing the most recentAfrican addition to the genus, S. croizatiana J. L\u00e9onard, a forest shrub from the DemocraticRepublic of Congo (DRC) [5]. The eight African species include Suregada africana Kuntze,and S. lithoxyla (Pax & K.Hoffm.) Croizat, S. zanzibariensis Baill, S. procera (Prain) Croizat,S. gossweileri (S.Moore) Croizat, S. ivorense (Aubr\u00e9v. & Pellegr.) J. L\u00e9onard, S. croizatiana J.L\u00e9onard and S. occidentale (Hoyle) Croizat. Suregada africana is a shrub or tree that grows upto 3 m. It was the first described of the African species, and is southernmost in distribution,extending along the coast in the thicket and dry woodland from KwaZulu-Natal andEastern Cape, through Eswatini to southern Mozambique [6]. Suregada zanzibariensis issympatric with the former species in KwaZulu-Natal but reaches 10 m tall and extends in acoastal thicket up the coast of East Africa through Tanzania, Mozambique, and Kenya tosouthern Somalia, west to Angola, and east to Madagascar. Suregada procera is a forest shrubor small tree species, 3\u20138 m tall that also extends from KwaZulu-Natal northwards, in highaltitude forests through Mozambique, Zimbabwe, Uganda, Zambia, Malawi, Tanzania,Kenya, eastern Democratic Republic of Congo (DRC) to South Sudan and Ethiopia [6].Suregada lithoxyla is a forest shrub native to Tanzania, and S. gossweileri is a forest shrub ofthe Maiombe Mountains of Angolan Cabinda and DRC. The two West African species areSuregada ivorense, a tall forest tree endemic to the Ivory Coast, and S. occidentale (Hoyle)Croizat, a 2\u20133 m tall forest shrub of the Ivory Coast to western Cameroon [5,7]. Of the32 species, pharmacological and phytochemical reports are available for only S. aequoreumHance., S. adenophora Baill., and S. angustifolia Baill. S. boiviniana Baill, S. gaultheriifoliaRadcl.-Sm, S. glomerulata (Blume) Baill., S. lanceolata (Willd.) Kuntze, S. multiflora (A. Juss.)Baill., and S. zanzibariensis Baill.The medicinal application of Suregada species has been attributed to the presenceof diverse chemical constituents such as diterpenoids, triterpenoids, flavonoids, etc. Inparticular, the diterpenoids about 73% isolated from Suregada species constitute the ma-jor chemical composition and exist as a diversity of different core skeletal frameworks.Diterpenoids, their chemical structure and biosynthesis pathways will be discussed. Sig-nificant research efforts have been made in isolating and evaluating the biological effectsof phytochemicals from the roots, stems, stem barks, leaves, and whole plant extracts ofthe Suregada species. Although different reports have been published about the medicinaluses, chemical constituents, and biological activities of Suregada species, currently, there isno review on the phytochemicals, pharmacological, and ethnomedicinal uses of the genusSuregada. Thus, our objective is to provide comprehensive insights into phytochemicals,pharmacological, and ethnomedicinal uses from Suregada species. Furthermore, the authorspreviously isolated compounds, ent-abietane diterpenoids, an unknown compound triv-ially named Mangiolide (34), and Jolkinolide B (35) from the Suregada species. Through areview of the literature, we aim to identify gaps in current knowledge related to Suregadaplant species and their compounds. These identified gaps can guide future research efforts,ensuring that the scientific community focuses on areas where further investigation is mostneeded. The information will serve as a guideline to the researchers and assist them infocusing their research on validating the claims made on the traditional folklore uses of theSuregada species and/or investigations to find new phytochemicals.2. Literature Search StrategyInformation about the ethnomedicinal, pharmacological activities, structure, andoccurrence, of action phytochemicals from Suregada species was obtained from publicationsextracted from Science Direct, PubMed, SciFinder, Springer Link, Wiley, Scopus, GoogleScholar, and Web of Science databases. The databases were searched for research articlesabout Suregada species. The syntax TITLE-ABSTRACT-KEY was used in combinationwith keywords like \u2018Suregada\u2019 OR \u2018genus\u2019 OR \u2018ethnomedicinal uses\u2019 OR \u2018constituentsof Suregada\u2019 OR \u2018biological activities of Suregada phytochemicals\u2019 OR \u2018antibacterial\u2019 ORPharmaceuticals 2023, 16, 1390 3 of 28\u2018cytotoxic activity\u2019 OR \u2018antiviral\u2019, OR \u2018anti-inflammatory\u2019. The search terms were runseparately or as a combination of terms depending on the database used for the periodbetween 2000 and 2022. The search resulted in over 100 reports mostly in the Englishlanguage, which we retrieved at our institution. The reports obtained information on earlydocuments on the taxonomy and research work articles on Suregada since historical times aswell as current reports. The obtained information from about 50 articles was carefully read,to obtain the publications meeting the aim of this work with a few older publications toreveal some necessary points. Only published work on Suregada was selected for this review.Due to the lack of human clinical trials, studies based on both in vitro and in vivo conditionswere contained within the review, but, only those studies that used isolated substances.3. Medicinal Uses of Suregada SpeciesThe medicinal uses of nine of the 32 Suregada plants are presented in Table 1 anddescribed below.3.1. Suregada adenophora Baill.Suregada adenophora (Figure 1) occurs throughout Madagascar and is used as a purgative [8].3.2. Suregada angustifolia (M\u00fcll.Arg.) Airy ShawSuregada angustifolia (Figure 1) is ground and mixed with water to prepare the paste,then applied to the body for the treatment of skin infections. When the S. angustifolia stembark is boiled with water and salt, it can be utilized as a mouthwash for treating toothache.Indian people in Kanis use S. angustifolia to treat skin infections and toothache [9].3.3. Suregada boiviniana Baill. (Suregada boiviniana var. boiviniana)Suregada boiviniana (Figure 1) aids in evacuating the placenta and treating dysentery,headache, cold, epilepsy, and malaria [10,11].3.4. Suregada decidua Radcl.-Sm.The fresh sap of S. decidua (Figure 1) from Western Madagascar is used to promotewound healing [8].3.5. Suregada lanceolata (Willd.) KuntzeThe shrub of the plant is used as an astringent [12]. S. lanceolata (Figure 1) is used fortreating skin diseases, worms, blood vomiting, piles, toothache, and weakness [13].3.6. Suregada lithoxyla (Pax & K.Hoffm.) CroizatThe wood of S. lithoxyla (Figure 1) is hard and used to make tool handles, spoons,firewood, and poles. The tree is suitable for ornamental purposes and is used for shade [14].3.7. Suregada multiflora (A. Juss.) Baill.Jahan et al. and Choudhary et al. stated that S. multiflora (Figure 1) is utilized totreat gum and hepatic ailments in traditional medicines [15,16]. According to the reportof Tewtrakul et al., S. multiflorum is mixed with other herbs and used as an anticancerrecipe, while in Thailand, it is used as a traditional medicine recipe (Table 1) [17]. Tewtrakulet al., further stated that the wood of S. multiflorum was used to treat pyrexia, eczema, andvenereal diseases; the roots of this plant are utilized to treat skin infection and lymphaticdisorders [17]. In Thailand, S. multiflora is utilized to treat skin diseases including rashes,itching, and inflammation [18]. In some regions, the granule products of this species can beprepared, which acts as a powerful organic herbicide [19]. In India, the seeds of S. multifloraare utilized in the treatment of liver diseases and as a gum tonic [20]. Suregada multiflora isharvested as timber to be used as firewood, rafters, and tool handles and cultivated as anornamental [21\u201323].Pharmaceuticals 2023, 16, 1390 4 of 283.8. Suregada procera (Prain) CroizatThis species is suitable for musical instruments, joinery, flooring, furniture, mine props,vehicle bodies, turnery precision equipment, interior trim, novelties, sporting goods, toys,agricultural implements, and draining boards [14]. The wood of S. procera (Figure 1) ishard and is used for firewood, handles, and poles in construction. The tree can be used forornaments and shade [14]. The S. procera stem is used to treat hemorrhoids and gonorrhea.The stem of S. procera is burnt and fired in the affected area [24].3.9. Suregada zanzibariensis Baill.Tanzanian people used S. zanzibariensis (Figure 1) stem bark and root extract for treat-ing ankylostomiasis. Its root extract is used to treat gonorrhea, stomachache, pneumonia,hernia, chest pains, and chicken pox, and as a purgative. The roots are drunk as an extractor chewed to treat snakebites, and Kenyan people use the roots to treat edema. Crushedleaves are ingested in porridge to expel worms and to treat dysentery. The powdered leavesare consumed in porridge or tea to treat poliomyelitis [25]. In Dares Salam, S. zanzibariensisleaves are boiled in water and applied topically or douched two times a day to treat vagi-nal candidiasis [26]. Tanzanian people mix S. zanzibariensis leaves with the Zanthoxylumchalybeum, and Acalypha fruticosa milled and scrubbed on the skin to treat skin infection [27].Giriama and Duruma people use a root decoction to treat body swelling. Digo peopleuse the root decoction for body pains, for pains during menstruation, and to avoid pre-mature birth [28,29]. The wood of S. zanzibariensis is hard and used for tool handles,building poles, spoons, withies, and firewood. The tree is used for shade, soil conservationnear the sea, and amenity. The roots are boiled, and the juice is drank twice a day as apurgative [14].Pharmaceuticals 2023, 16, x FOR PEER REVIEW 4 of 30 itching, and inflammation [18]. In some regions, the granule products of this species can be prepared, which acts as a powerful organic herbicide [19]. In India, the seeds of S. mul-tiflora are utilized in the treatment of liver diseases and as a gum tonic [20]. Suregada mul-tiflora is harvested as timber to be used as firewood, rafters, and tool handles and culti-vated as an ornamental [21\u201323]. 3.8. Suregada procera (Prain) Croizat This species is suitable for musical instruments, joinery, flooring, furniture, mine props, vehicle bodies, turnery precision equipment, interior trim, novelties, sporting goods, toys, agricultural implements, and draining boards [14]. The wood of S. procera (Figure 1) is hard and is used for firewood, handles, and poles in construction. The tree can be used for ornaments and shade [14]. The S. procera stem is used to treat hemorrhoids and gonorrhea. The stem of S. procera is burnt and fired in the affected area [24]. 3.9. Suregada zanzibariensis Baill. Tanzanian people used S. zanzibariensis (Figure 1) stem bark and root extract for treat-ing ankylostomiasis. Its root extract is used to treat gonorrhea, stomachache, pneumonia, hernia, chest pains, and chicken pox, and as a purgative. The roots are drunk as an extract or chewed to treat snakebites, and Kenyan people use the roots to treat edema. Crushed leaves are ingested in porridge to expel worms and t treat dysentery. The powdered leaves are consumed in porri ge or tea t treat poliomyeli is [25]. In Dares Salam, S. zan-zibariensis leaves are boiled in water and applied topically or douched two times a day to treat vaginal candidiasis [26]. Tanzanian people mix S. zanzibariensis leaves with the Zan-thoxylum chalybeum, and Acalypha fruticosa milled and scrubbed on the skin to treat skin infection [27]. Giriama and Duruma people use a root decoction to treat body swelling. Digo people use the ro t decoction for body pains, for pains during menstruation, and to avoid premature birth [28,29]. The wood of S. zanzibariensis is har and used for tool han-dles, building poles, spoons, withies, and firewood. The tree is used for shade, soil con-servation near the sea, and amenity. The roots are boiled, and the juice is drank twice a day as a purgative [14]. Figure 1. The plant species of Suregada (a) S. adenophora, (b) S. angustifolia, (c) S. boiviniana, (d) S. decidua, (e) S. lanceolata, (f) S. lithoxyla, (g) S. multiflora, (h) S. procera, (i) S. zanzibariensis [1,30\u201333]. Figure 1. The plant species of Suregada (a) S. adenophora, (b) S. angustifolia, (c) S. boiviniana,(d) S. decidua, (e) S. lanceolata, (f) S. lithoxyla, (g) S. multiflora, (h) S. procera, (i) S. zanzibariensis [1,30\u201333].Pharmaceuticals 2023, 16, 1390 5 of 28Table 1. Some reported ethnomedicinal uses of Suregada species.Plant Plant Part Uses ReferencesS. adenophora Unspecified Purgative [8]S. angustifolia Stem bark Skin infections, toothache [9]S. boivinianaUnspecified Purgative [10]Leaves Headaches and cold, dysentery, malaria,placenta apposition and epilepsy [10,11]S. decidua Fresh sap Wounds [8]S. lanceolata/S. angustifoliaShrub Astringent [12]Whole plant Skin diseases, worms, weakness, bloodvomiting, piles, toothache [13]S. lithoxylia Wood Poles, fuel, spoons, tool handles [14]S. multifloraWood Eczema, venereal diseases, and pyrexia[17]Roots Lymphatic disorders, skin diseasesBarkLymphatic disorder, hepatitis, skin diseases,fungal infection, venereal diseases,and leprosyWhole Plant Pneumonia, fever, poisonous effects, stomachdisorder, squint eye, and gum diseaseS. proceraWood Poles, handles, and firewood[14]Tree Ornaments and shadeStem Hemorrhoids, gonorrhea [24]S. zanzibariensisLeaves Asthma, malaria, skin diseases, dysentery,vaginal candidiasis and abdominal pains [21,26,27,29]Roots and stem bark Ankylostomiasis [25,29]RootsGonorrhoea, chest pain, stomach ache,hernia, chicken pox, schistosomiasis, bodyswelling, pneumonia and purgative[14,25]Wood Building poles, tool handles, withies, fueland spoons [14]4. Phytochemical Composition of the Suregada GenusAlthough Suregada species are more valued plant species for their medicinal properties,only a few species have been studied for their ethnomedicinal and phytochemistry. Thereare wide discrepancies among the published results on the species\u2019 primary metabolitecontent with diterpenoids frequently isolated. The literature reports 114 phytochemicalsfrom the genus Suregada which were classified into diterpenoids (1\u201371), triterpenoids(72\u201381), alkaloids (82\u201384), flavonoids (85\u201390), lignans (92\u201394), amino acids (95\u2013104) andiminosugars (105\u2013114) [1,15,16,34,35] as shown in Figure 2. Diterpenoids were the majorconstituents reported from the genus. Most of the isolated metabolites were not evaluatedfor their pharmacological properties which limits their transition to clinical trials. Thereports show that the phytochemical investigation of Suregada species has not been exploredfully. Hence, future studies should aim at exploring the phytopharmacological propertiesof Suregda species.Pharmaceuticals 2023, 16, 1390 6 of 281 Figure 2. Representation of different metabolites in genus Suregada.4.1. DiterpenoidsDiterpenoids are a class of natural products known for their structural diversity.Diterpenoids isolated from Suregada genera belong to ent-abietane, diterpene lactone, ent-kuarane, and ent-pimaranes classes [36,37]. Ditepenoids consist of four isoprene unitswhich form a 20-carbon backbone. The core structures for diterpenoids are classified intomacrocyclic, bicyclic, linear, tricyclic, tetracyclic, and pentacyclic types [38]. Naturally,occurring diterpenoids are often found in different polyoxygenated forms with hydroxylgroups, formyl and carbonyl groups, or lactones. There are different types of diterpenoidssuch as ent-abiatane (1\u201359), ent-kaurane (60\u201371), etc. Ent-abietane diterpenoids were re-ported to exhibit a wide spectrum of biological activities such as cytotoxic, anti-microbial,anti-cancer, and anti-inflammatory [39]. Ent-Abietanes with a lactone ring are classified asone of the main bioactive compounds. For example, jolkinolide B (35) is well-known forits anti-tumor activity [39]. Ent-abietanes diterpenoids often contain an \u03b1, \u03b2-unsaturated\u03b3-lactone ring. Some carbons of abietane diterpenoids, form a double bond or are sub-stituted with hydroxyl or keto groups [40]. The varying skeletal structures of diterpenesresult from geranylgeranyl pyrophosphate (GGPP) and are classified according to theirbiosynthetic pathways and cyclization patterns [41]. According to Dewick diterpenesstart from geranylgeranyl diphosphate (GGPP), formed by the addition of an isopentenyldiphosphate (IPP) molecule to Farnesyl diphosphate (FPP) [41]. Cyclization of GGPPmediated by carbocation formation, allows many structural alternatives of diterpenoids tobe formed [41]. Dewick further mentioned that during cyclization, the loss of diphosphateoccurs which generates the first carbocation, and several natural diterpenes have beenformed by varying mechanisms through cyclization [41].The formation of carbocation formation begins by protonation of the double bond atthe head of the chain, which leads to the initial cyclization sequence. Furthermore, theloss of the diphosphate later on gives rise to a carbocation and causes further cyclization.Protonation of GGPP can start a joint cyclization sequence, the loss of a proton froma methyl terminates the cyclization sequence, producing (\u2212)-copalyl PP [41]. Foldingof the substrate on the enzyme surface controls the stereochemistry of (\u2212)-copalyl PP.Nevertheless, alternate folding results in (+)-copalyl PP (labdadienyl PP), the enantiomer of(\u2212)-copalyl PP, which has an opposite configuration at the newly produced chiral centers.From (\u2212)-copalyl PP, several cyclizations and a rearrangement, all catalyzed by a singleenzyme kaurene synthase, produce ent-kaurene [42]. Formation of ent-kaurene involvesthe loss of the diphosphate leaving group which enables the carbocation-mediated productof the third ring system, which then forms the fourth ring [41].Earlier the biosynthesis of ent-kaurane was described, the latter is the suggested biosyn-thesis of ent-abietane diterpenoid. The suggested biosynthesis of ent-abietane lactones isPharmaceuticals 2023, 16, 1390 7 of 28shown in Scheme 1 [42]. Some of the ent-abietane lactones including Jolikinolide (35) maybe biosynthesized from the ent-neoabietadiene. The oxidation of ent-neoabietadiene couldlead to an intermediate labeled (a). Then, the intermediate (a) might be oxidized to obtainintermediate (b) and (c) [42]. The highly oxidized ent-abietane diterpenoid skeleton (c) mayundergo a series of intramolecular cyclization, oxidation, and dehydration reactions toproduce the ent-abietane diterpenoids bearing an additional five-membered lactone ring,including 35 [42].Pharmaceuticals 2023, 16, x FOR PEER REVIEW 7 of 30 Earlier the biosynthesis of ent-kaurane was described, the latter is the suggested bio-synthesis of ent-abietane diterpenoid. The suggested biosynthesis of ent-abietane lactones is show in Sch me 1 [42]. Some of the ent-abietane lactones including Jolikinolide (35) may be biosynthesized from the ent-n oabietadiene. The oxidation of ent-neoabietadiene could lead to an intermediat labeled (a). The , the intermediate (a) might be oxidized to obtain intermediate (b) and (c) [42]. The highly oxidized ent-abietane diterpenoid skeleton (c) may undergo a series of intramolecular cyclization, oxidation, an dehydration reac-tions to produce the ent-abietane diterpenoids bearing an additional five-membered lac-tone ring, including 35 [42]. HOPPHHHent-copalyl PP ent-pimaradieneHHOOOa)HHOOOOHHOO\u2013OOdemeth-ylationcyclizationHHOOHOOHHOOOdehydrationHHOOOO35b)c)d)e)[O] [O][O][O] Scheme 1. Suggested biosynthesis of some ent-abietane lactones including Jolkinolide B (35). Oxi-dation of ent-neoabietadiene led to the formation of intermediate (a). Oxidation of (a) could lead to the production of intermediate (b). Intermediate (c) was produced from a possible demethylation of (b). Intermediate see may undergo cyclization to yield (d). Dehydration of intermediate (d) pro-duces intermediate (e). Studies conducted on Suregada indicated the presence of several types of diterpe-noids. In particular, compounds 1\u201359, the ent-abietane diterpenoids containing an addi-tional five-membered lactone ring, revealed important pharmacological anti-tumor and anti-inflammatory activities to name a few. The specific functional groups besides the lac-tone ring in these ent-abietane diterpenoids can differ depending on the compound\u2019s bi-osynthetic origin and its specific modifications [43]. These functional groups such as hy-droxyl, epoxide, acetates, ketones, and alkene collectively contribute to the compound\u2019s chemical and biological properties, making ent-abietane diterpenoids a diverse group of natural products with various potential applications in pharmacology, medicine, and Scheme 1. Suggested biosynthesis of some ent-abietane lactones including Jolkinolide B (35). Oxida-tion of ent-neoabietadiene led to the formation of intermediate (a). Oxidation of (a) could lead to theproduction of intermediate (b). Intermediate (c) was produced from a possible demethylation of (b).Intermediate see may undergo cyclization to yield (d). Dehydration of intermediate (d) producesintermediate (e).Studies conducted on Suregada indicated the presence of several types of diterpenoids.In particular, compounds 1\u201359, the ent-abietane diterpenoids containing an additionalfive-membered lactone ring, revealed important pharmacological anti-tumor and anti-inflammatory activities to name a few. The specific functional groups besides the lactonering in these ent-abietane diterpenoids can differ depending on the compound\u2019s biosyn-thetic origin and its specific modifications [43]. These functional groups such as hydroxyl,epoxide, acetates, ketones, and alkene collectively contribute to the compound\u2019s chemicaland biological properties, making ent-abietane diterpenoids a diverse group of naturalproducts with various potential applications in pharmacology, medicine, and other fieldsof research. The biological activities of ent-abietane diterpenoids are often related to theirinteractions with specific molecular targets in biological systems, and the presence ofparticular functional groups can be crucial for these interactions [43].Pharmaceuticals 2023, 16, 1390 8 of 28Diterpenoids are named by making use of the main name of their skeletons. Ifthe backbone of the diterpenoid comprises many functional groups namely carboxylic,aldehyde groups, lactone, or olefinic carbons, their position will be named according tothe numbering of the skeleton, and the name will be followed by the suffix -oic, -al, -olide,or -en, respectively [43]. The presence of hydroxyl and epoxide groups is named beforethe parent name. Greek letters \u03b1 or \u03b2 are utilized when a hydroxyl, epoxide, acetoxyl, orcoumaroyl group in the compound is, respectively, upon or behind the plan of the skeleton[Sandjo, Rubinger] such as compounds 33, 36\u201341, etc. The location of epoxide, hydroxylgroups, and other substituents in the diterpene cores are given between the terms ent, syn,or neo and the name of the skeleton. The stereochemistry at C-9 and C-10 in the decalinpart (ring A and B) of most diterpenoids can be cis or trans, depending on their orientation,and the naming syn and ent are utilized. When C-20 and C-11 are behind the compoundplan, the prefix ent will follow the parent name [43].The number of carbons (20 signals of carbons) seen on the 13C-NMR spectrum couldsuggest that the compound is a diterpenoid. Moreover, some of the abietane, kaurane, andlabdane scaffolds that do not possess any functional group on the decalin moiety such ascompounds 10 and 35 exhibit carbon signals of C-1 (CH2), C-2 (CH2), C-3 (CH2), C-5 (CH),and C-6 (CH2) around \u03b4 40.1, 18.2, 42.0, 56.0, and 20.0, respectively [44] (Figure 3c). Methylgroups C-18, 19, and 20 are seen around \u03b4 33.1, 21.5, and 18.0, respectively. Both C-18and 19 have Heteronuclear Multiple-Bond Correlation spectroscopy (HMBC) interactionsand they correlate with C-3 (\u03b4 42.0), C-4 (\u03b4 33.1), and C-5 (\u03b4 56.0) [43,44]. Ent-abietanesditerpenoids usually contain an \u03b1, \u03b2-unsaturated \u03b3-lactone ring connected at C-12 andC-13. Some carbons of abietane diterpenoids, like C-8, C-14, C-11, and C-12, form a doublebond or can be substituted with hydroxyl or keto groups [40]. According to the reportsobtained from the search, the structure\u2013activity relationship of compounds isolated fromSuregada species was not evaluated. The structure\u2013activity relationship of some reportedditerpenes revealed that acetylation and esterification of hydroxyl groups, particularly atC-3 and C-8, have a positive effect on activities [40].The 1H NMR spectrum of compound 4 (Figure 1) showed the presence of a trisub-stituted cyclopropane ring. Two upfield resonances of the C-18 cyclopropane methyleneprotons H-18 (exo), \u03b4H \u22120.01, and H-18 (endo), \u03b4H 0.40 at \u03b4C 21.8, the H-3 signal at \u03b4H0.54 at \u03b4C 19.1, and one quaternary carbon resonance (C-4, \u03b4C 16.1) confirmed the presenceof a trisubstituted cyclopropane ring in ring A. Jahan further confirmed that these valuesaligned with the values reported for the metasequoic acids that were reported as a novelskeleton from the investigation of phytochemicals from Merasaquoia glyptostroboide [45]containing a trisubstituted cyclopropyl substituent in ring A of a labdane skeleton. Com-pounds 5, 6, and 7 had similar NMR signals that indicated the presence of a cyclopropanegroup. All these compounds were deduced to have a rearranged abietane skeleton [34].The cyclopropyl ring on the ent-abietane or ent-abietane lactones is rare. Several modifiedpimarane diterpenoids and tiglianes contain the cyclopropane system [45].Kalenga reported that modified ent-abietane diterpenoids with a terminal olefinicbond at C-4, such as in compounds 58 and 59, are rare. The terminal double bond at C-4 isproposed to arise through an enzymatic 1,2-methyl shift, either of CH3-18 or CH3-19, fromC-4 to C-3, followed by dehydrogenation [46]. The suggested biosynthesis for compounds58 and 59 is shown in Scheme 2 [46]. The oxidation of ent-copalyl PP leads to the productionof ent-pimaradiene. Then, the ent-pimaradiene could be oxidized to obtain an intermediatecontaining a lactone ring which is an ent-abietane diterpenoid skeleton. The ent-abietanediterpenoid skeleton may undergo a series of transformations namely, hydrogenation, anddehydrogenation, and then followed by enzymatic 1.2 methyl shift to produce compound58 or epoxidation for compound 59 [46].Pharmaceuticals 2023, 16, 1390 9 of 28Pharmaceuticals 2023, 16, x FOR PEER REVIEW 9 of 30 OHHHOHOHHHOOOHHH1 2 39 10 11 12OOHHH OHOH4OHH O5OHHOAcH O15OOOOOAcHOHHH OHAcOHOAcOHHH1617ORHOHOO18OOHHOHOHOHH6OOHHHOHOHOHH7OHOHHHHOOO14O OO OHHH HOH H OHOAcOH19 20OHOHOHHO HOOOOOOOHHOAcOHOAcOHOHOOOH OOHHOOHOHHOOOOAcOOAcOH OOHH8OOAcH OOHH13O (a) Pharmaceuticals 2023, 16, x FOR PEER REVIEW 10 of 30 (b) O OO OO O O OO OO OO OO OO OH H HHH H HHHHHH HH H HH HHHOAcH OOH H OAcOOAcAcOOAcHOOAcOOAcOAcOH OHOAcOHOAcHOH OH OHAcO AcOH HOAcOAcOHHOAcH OHOAcOHHOHOHOH OH21 2322 2425 26 27 2829 30O OOHOHOOHHOHOH31OHOHOOHHH OHHOH32OHOOHHHOAcOOHOH33OOOOAcHH34OOHH OO35Figure 3. Cont.Pharmaceuticals 2023, 16, 1390 10 of 28Pharmaceuticals 2023, 16, x FOR PEER REVIEW 11 of 30 OOOHOHHOH36OOHOHOHH37OOOHHH38 R=OH39 R=HOOHHOO40OOR2R1R3 HR4OHH48 R1, R2=O, R3, R4=OAc49 R1, R2=O, R3=OH, R4=H53 R1=R2=R4=H, R3=OAc54 R1=R2=H, R3=R4=OAc55 R1=R2=O, R3=OAc, R4=HOOHHHHO41OOOHOHH OHOOO42OCH3OCH3OHHO43OOOOHHO44OHHHHO45 47OOHR2R1AcO HH OHOH50 R1=R2=H52 R1=R2=OOOOOHHOAcOHHH51OOOHHHOR56 R=H57 R=OAcOOHH46OHOHOOHOHHOOOHOHHOO58 59R (c) Figure 3. (a). Abiatane-type diterpenoids were isolated from Suregada species. (b). Abiatane-type diterpenoids were isolated from Suregada species. (c). Abiatane-type diterpenoids were isolated from Suregada species. The 1H NMR spectrum of compound 4 (Figure 1) showed the presence of a trisubsti-tuted cyclopropane ring. Two upfield resonances of the C-18 cyclopropane methylene pro-tons H-18 (exo), \u03b4H -0.01, and H-18 (endo), \u03b4H 0.40 at \u03b4C 21.8, the H-3 signal at \u03b4H 0.54 at \u03b4C 19.1, and one quaternary carbon resonance (C-4, \u03b4C 16.1) confirmed the presence of a trisubstituted cyclopropane ring in ring A. Jahan further confirmed that these values aligned with the values reported for the metasequoic acids that were reported as a novel skeleton from the investigation of phytochemicals from Merasaquoia glyptostroboide [45] containing a trisubstituted cyclopropyl substituent in ring A of a labdane skeleton. Com-pounds 5, 6, and 7 had similar NMR signals that indicated the presence of a cyclopropane group. All these compounds were deduced to have a rearranged abietane skeleton [34]. Figure 3. (a) Abiatane-type diterpenoids were isolated from Suregada species. (b) Abiatane-typediterpenoids were isolat d from Suregada species. (c) Abiatane-type diterpenoids were isolated fromSuregada species.Pharmaceuticals 2023, 16, x FOR PEER REVIEW 12 of 30 The cyclopropyl ring on the ent-abietane or ent-abietane lactones is rare. Several modified pimarane diterpenoids and tiglianes contain the cyclopropane system [45]. Kalenga reported that modified ent-abietane diterpenoids with a terminal olefinic bond at C-4, such as in compounds 58 and 59, are rare. The terminal double bond at C-4 is proposed to arise through an enzymatic 1,2-methyl shift, either of CH3-18 or CH3-19, from C-4 to C-3, followed by dehydrogenation [46]. The suggested biosynthesis for com-pounds 58 and 59 is shown in Scheme 2 [46]. The oxidation of ent-copalyl PP leads to the production of ent-pimaradiene. Then, the ent-pimaradiene could be oxidized to obtain an intermediate containing a lactone ring which is an ent-abietane diterpenoid skeleton. The ent-abietane diterpenoid skeleton may undergo a series of transformations namely, hy-drogenation, and dehydrogenation, and then followed by enzymatic 1.2 methyl shift to produce compound 58 or epoxida ion f r co pound 59 [46].OPPHOPPHHHHHOOOHHOOOHHOOOHHOOOHOHHOOOHOHHOOOHHOOGeranylgeranly pyrophosphate ent-copalyl PP ent-pimaradienedehydro-genationhydration1,2-CH3 shift8,14-epoxidation58 59[O][O][H] -H2 Scheme 2. Suggested biosynthesis for compounds 58 and 59. The chemical structures of the diterpenoids isolated from Suregada species are dis-cussed below. 4.2. Abiatane-Type Diterpenoids Abietanes are tricyclic diterpenoids found in nature that have been isolated from a variety of terrestrial plant sources. Araucariaceae, Cupressaceae, Phyllocladaceae, Pina-ceae, and Podocarpaceae families, as well as some species from Asteraceae, Celstraceae, Hydrocharitaceae, and Lamiaceae families, and even some fungi species, are known to contain abietane diterpenoids. Abietane diterpenoids have a wide range of biological ac-tivities. Apart from the antimicrobial, antiviral, antimalarial, antiulcer, anti-leishmaniasis, and antioxidant activities reported by the scientists, they also reveal antitumor-promoting activity and antivirus properties by inhibiting the reproduction of viruses such as herpes simplex virus type 1 (HSV-1), cytomegalovirus (CMV), varicella zoster virus (VZV), and Epstein-Barr virus [17,36,47]. Aromatic abietanes are the most abundant abietane group. Scheme 2. Suggested biosynthesis for compounds 58 and 59.Pharmaceuticals 2023, 16, 1390 11 of 28The chemical structures of the diterpenoids isolated from Suregada species are dis-cussed below.4.2. Abiatane-Type DiterpenoidsAbietanes are tricyclic diterpenoids found in nature that have been isolated from avariety of terrestrial plant sources. Araucariaceae, Cupressaceae, Phyllocladaceae, Pinaceae,and Podocarpaceae families, as well as some species from Asteraceae, Celstraceae, Hy-drocharitaceae, and Lamiaceae families, and even some fungi species, are known to containabietane diterpenoids. Abietane diterpenoids have a wide range of biological activities.Apart from the antimicrobial, antiviral, antimalarial, antiulcer, anti-leishmaniasis, andantioxidant activities reported by the scientists, they also reveal antitumor-promotingactivity and antivirus properties by inhibiting the reproduction of viruses such as herpessimplex virus type 1 (HSV-1), cytomegalovirus (CMV), varicella zoster virus (VZV), andEpstein-Barr virus [17,36,47]. Aromatic abietanes are the most abundant abietane group.Aromatic abietanes are primarily represented by dehydroabietic acid and ferruginol. Aro-matic abietanes, like most diterpenoids, are mostly known as chemical defense agents.Antimicrobial, antileishmanial, antiplasmodial, antifungal, antitumor, cytotoxicity, antivi-ral, antiulcer, cardiovascular, antioxidant as well and antiinflammatory activities are thebiological activities of this group reported up to now. Various diterpenoids have beenassigned structures that could be derived by adjusting or cleaving the abietane skeleton,known as rearranged abietane. Triptergulides A and B are novel rearranged abietanediterpenes isolated from Tripterygium wilfordii (Celastraceae), a medicinal plant usedin Traditional Chinese Medicine to treat a variety of diseases including systemic lupuserythematosus, psoriasis, ankylosing spondylitis, and idiopathic IgA nephropathy. Over 59(1\u201359) ent-abietane-type diterpenoids were isolated from Suregada species which remainsthe abundant diterpenoids from the genus.Ent-abietane and ent-kuarane diterpenoid lactones were isolated from S. multiflora, S.glomerulata, S. aequorea and S. zanzibariensis. The dichloromethane extract of S. multiflorabark afforded three tetracyclic diterpene lactones; helioscopinolide A (1), helioscopinolideC (2) and helioscopinolide I (3) (Figure 1a) [17,36]. Suregadolides A and B (4 and 5) wereisolated from the dichloromethane extract of S. multiflora bark (Figure 1a). Dichloromethane-methane extract of S. multiflora bark afforded suregadolides C (6) and D (7) (Figure 1a)these compounds were found to possess a novel skeleton, containing a cyclopropanering bridging at C-3 and C-4 of the abietane skeleton [16,34]. Gelomulides A-F (8\u201313)were isolated from the S. multiflorum leaves (Figure 1a) [48]. S. multiflora leaves werereinvestigated and led to the isolation of Suremulide A (14) and gelomulides G-J (15\u201318)(Figure 3a) [15,16,34,49].Lee et al. reported the isolation of ent-abietane diterpenes, namely, gelumolideK-X (19\u201332) (Figure 3a,b) and 6\u03b2-acetoxy-1-one-8\u03b2,14-\u03b1-dihydroxy-ent-abieta2(3),13(15)-diene,12-olide (33) [35] from the dichloromethane extract of S. aequorea.Mangisa et al., isolated 6-acetoxy-14-keto-ent-abieta-7(8),13(15)-diene-16,12-olide) triv-ially named mangiolide (34) and 8,13-diepoxy-13,15-ent-abietene-16,12-olide, Jolkinolide B(35) from the dichloromethane-methanol extract of S. zanzibariensis, (Figure 3b) [50].Ent-abiatene diterpenoids 7\u03b2,8\u03b1\u03b2-dihydroxy-12-oxo-ent-abietan-16,14-olide (36), 3,4,18\u03b2-cyclopropa-7\u03b2,17-dihydroxy-ent-abieta-8(14),13(15)-dien-16,12-olide (37), 3\u03b1,7\u03b2-dihydroxy-ent-abieta-8(14),13(15)-dien-16,12-olide (38), 7\u03b2-hydroxy-ent-abieta-8(14),13(15)-dien-16,12-olide (39), 3-oxo-8\u03b2,14\u03b2-epoxy-ent-abieta-11,13(15)-dien-16,12-olide (40), 13\u03b1-Hydroxy-14\u03b1,16-epoxy-ent-abieta-7-en-3-one (41), 7-Oxo-ent-abieta-5,8(14),13(15)-trien-16,12-olide(42), Methyl 12-hydroxy-3-oxo-ent-abieta-8,11,13-trien-17-oate (43), 3-oxo-jolkinolide B(44), 3,4,18b-cyclopropa-ent-abieta-8(14),13(15)-dien-16,12-olide (45) and 7\u03b2,17-dihydroxy-ent-abieta-8(14),13(15)-dien-16,12-olide (46) were isolated from the ethanol extract of S.glomerulata roots (Blume) Baill. [51\u201353].Dichloromethane-methanol extract of S. multiflora leaves afforded 3\u03b2-Hydroxy-8,14\u03b2:11,12\u03b1-diepoxy-13(15)-abietane-16,12-olide (47) [53]. Investigation of methanol-dichloromethane (1:1)Pharmaceuticals 2023, 16, 1390 12 of 28extract of S. multiflora leaves afforded ten diterpene lactones namely, 3\u03b2,6\u03b2-diacetoxy-1-one-8\u03b2,14\u03b2-epoxy-13,15-abiatene-16,12-olide (48), 3\u03b2-hydroxy-1-one-8\u03b2,14\u03b2-epoxy-13,15-abiatene-16,12-olide (49), 3\u03b2-acetoxy-8\u03b2,14\u03b1-dihydroxy-13,15-abiatene-16,12-olide (50), 6\u03b2-acetoxy-2-ene-8\u03b2,14\u03b1-dihydroxy-1-one-13,15-abiatene-16,12-olide (51), 3\u03b2-acetoxy-8\u03b2,14\u03b1-dihydroxy-1-one-13,15-abiatene-16,12-olide (52), 3\u03b2-acetoxy-8\u03b2,14\u03b2-epoxy-13,15-abiatene-16,12-olide (53), 3\u03b2,6b-diacetoxy-8\u03b2,14\u03b2-epoxy-13,15-abiatene-16,12-olide (54), 3\u03b2-acetoxy-1-one-8\u03b2,14\u03b2-epoxy-13,15-abiatene-16,12-olide (55), 2-ene-1-one-8\u03b2,14\u03b2-epoxy-13,15-abiatene-16,12-olide (56), and 6\u03b2-acetoxy-2-ene-1-one-8\u03b2,14\u03b2-epoxy-13,15-abiatene-16,12-olide (57) [15].S. zanzibariensis leaf extract yielded zanzibariolides A (58) and B (59) [46].4.3. Kaurene-Type DiterpenoidsCheenpracha et al., Jahan et al., and Tewtrakul et al. investigated the active dichloromethaneextract of the S. multiflora stem bark which yielded several diterpenoids ent-kaurene diter-penoids, ent-16-kauren-3\u03b2,15\u03b2,18-triol (60), and ent-3-oxo-16-kauren-15\u03b2,18-diol (61) to-gether with ent-16-kaurene-3\u03b2,15\u03b2-diol (62), and abbeokutone (63) (Figure 4) [16,17,36].According to Gondal, Jahan et al., and Tewtrakul et al., Suremulol A (64) and SuremulolB (65) were also isolated from S. multiflora (Figure 2) [16,17,51]. He et al., and Yan et al.,stated that the ethanol extract of S. glomerulata roots yielded 1\u03b1,16\u03b1,17-Trihydroxy-ent-kaurane (66), euphoranginol B (67), corymbol (68), and ent-kaurane-3\u03b2,16\u03b2,17-triol (69)(Figure 4) [52,53].Pharmaceuticals 2023, 16, x FOR PEER REVIEW 14 of 30 Cheenpracha et al., Jahan et al., and Tewtrakul et al. investigated the active dichloro-methane extract of the S. multiflora stem bark which yielded several diterpenoids ent-kaurene diterpenoids, ent-16-kauren-3\u03b2,15\u03b2,18-triol (60), and ent-3-oxo-16-kauren-15\u03b2,18-diol (61) together with ent-16-kaurene-3\u03b2,15\u03b2-diol (62), and abbeokutone ( 3) (Figure 4) [16, 17, 36}. According to Gondal, Jahan et al., and Tewtrakul et al., Suremulol A (64) and Suremulol B (65) were lso isol ted from S. multiflora (Figure 2) [16,17,51]. He et al., and Yan et al., stated that the ethanol extract of S. glomerulata roots yielded 1\u03b1,16\u03b1,17-Trihy-droxy-ent-kaurane (66), euphoranginol B (67), corymbol (68), and ent-kaurane-3\u03b2,16\u03b2,17-triol (69) (Figure 4) [52,53]. OHHHHOOHOHHHOOHOHHHHO HHOOHOHHHHHHOOHOHAcOOHOHOH64 6560 61 6266HHOHOH63OHHHOHH67OHHHOH68HHOH69OHOHOHOHHOO OOHOOHHHOH70OHHHO71 Figure 4. Structures of kaurene and ent-pimarane-type diterpenoids from Suregada species. 4.4. Ent-Pimarane Diterpenoids Jahan et al. investigated S. multiflora which yielded bannaringaolide A (70) (Figure 5) [16]. A diterpene lactone of an ent-pimarane skeleton, 17-hydroxy-ent-pimara-8(14),15-dien-3-one (71) was isolated from the ethanol extract of S. glomerulata roots [52]. Figure 4. Structures of kaurene and ent-pimarane-type diterpenoids from Suregada species.4.4. Ent-Pimarane DiterpenoidsJahan et al. investigated S. multiflora which yielded bannaringaolide A (70) (Figure 5) [16].A diterpene lactone of an ent-pimarane skeleton, 17-hydroxy-ent-pimara-8(14),15-dien-3-one (71) was isolated from th ethanol extract of S. glomerulata roots [52].Pharmaceuticals 2023, 16, 1390 13 of 28i l , , x FOR PEER REVIEW 15 of 30 Figure 5. Structures of triterpenoids isolated from S. multiflora. 4.5. Triterpenoids Sengupta and Khastgir reported the isolation of three triterpenoids, namely: 7-mul-tifloren-3\u03b2-ol (72), 7-multifloren-3\u03b1-ol (73), and baurenol (74) (Figure 6) from the bark ex-tract of S. multiflora [54]. Baurenol (74) was also isolated from S. angustifolia. Venkatesan et al. reported six compounds, epi-friedelinol (75), friedelin (76), and \u03b1-amyrin (77) from S. angustifolia stem bark [9]. \u03b1-amyrin (77) and simiarenol (78) were also isolated from S. zanzibariensis leaves extract [46]. Figure 6. Structures of fatty alcohol, steroidal glycoside, and phytosterols isolated from S. angustifo-lia. HOHHH HOHHHHHHHOHOHHHHHHOHOH HH72 73 7475 76 7778H HHOH(CH2)27CH3HO79HHOHHOHOOHHOHO80HHHOHH81Figure 5. Structures of triterpenoids isolated from S. multiflora.4.5. TriterpenoidsSengupta and Khastgir reported the isolation of three triterpenoids, namely: 7-multifloren-3\u03b2-ol (72), 7-multifloren-3\u03b1-ol (73), and baurenol (74) (Figure 6) from the barkextract of S. multiflora [54]. Baurenol (74) was also isolated from S. angustif lia. V nkatesanet al. reported six compounds, epi-friedelinol (75), friedelin (76), and \u03b1-amyri (77) fromS. angustifolia stem bark [9]. \u03b1-amyrin (77) and simiarenol (78) were also isolated fr .zanzibariensis leaves extract [46].Pharmaceuticals 2023, 16, x FOR PEER REVIEW 15 of 30 Figure 5. Structures of triterpenoids isolated from S. multiflora. 4.5. Triterpenoids Sengupta and Khastgir reported the isolation of three triterpenoids, namely: 7-mul-tiflore -3\u03b2-ol (72), 7-multifloren-3\u03b1-ol (73), nd baurenol (74) (Figure 6) from the bark ex-tract of S. multiflora [54]. Baurenol (74) was lso isolated from S. angustifolia. Venkatesan et al. reported six compounds, epi-friedelinol (75), friedelin (76), and \u03b1-amyrin (77) from S. angustifolia stem bark [9]. \u03b1-amyrin (77) and simiarenol (78) were also isolated from S. zanzibariensis leaves extract [46]. Figure 6. Structures of fatty alcohol, steroidal glycoside, and phytosterols isolated from S. angustifo-lia. HOHHH HOHHHHHHHOHOHHHHHHOHOH HH72 73 7475 76 7778H HHOH(CH2)27CH3HO79HHOHHOHOOHHOHO80HHHOHH81Figure 6. Structures of fatty alcohol, steroidal glycoside, and phytosterols isolated from S. angustifolia.Pharmaceuticals 2023, 16, 1390 14 of 284.6. Fatty Alcohol, Steroidal Glycoside and Phytosteroln-Octacosanol (79), \u03b2-sitosterol-3-\u03b2-D-glucopyranoside (80), and \u03b2-sitosterol (81) wereisolated from S. angustifolia stem bark [9].4.7. AlkaloidsYan et al. explored S. glomerulata leaves (Blume) Baill., which afforded three pyrrolidine al-kaloids, namely 5\u03b2-carboxymethyl-3\u03b1-hydroxy-2\u03b2-hydroxymethyl-1,1-dimethylpryrrolidine(82), 5\u03b2-carboxymethyl-3\u03b1-hydroxy-2\u03b2-hydroxymethyl-1-methylpryrrolidine (83) and 2\u03b1-carboxymethyl-5\u03b1-dimethylamino-4\u03b1-hydroxy-tetrahydrpyran (84) (Figure 7) [52]. Poly-hydroxyalkaloids such as trimethylsilyl (TMS) derivatives of \u03b1-homonojirimycin wereisolated from S. gaultheriifolia Radcl.-Sm leaves and S. adenophora leaf fragment [55].Pharmaceuticals 2023, 16, x FOR PEER REVIEW 16 of 30 4.6. Fatty Alcohol, Steroidal Glycoside and Phytosterol n-Octacosanol (79), \u03b2-sitosterol-3-\u03b2-D-glucopyranoside (80), and \u03b2-sitosterol (81) were isolated from S. angustifolia stem bark [9]. 4.7. Alkaloids Yan et al. expl red S. glomerulata leaves (Blume) Baill., which afforded three pyrroli-dine alkaloids, namely 5\u03b2-carboxymethyl-3\u03b1-hydroxy-2\u03b2-hydroxymethyl-1,1-dimethyl-pryrrolidine (82), 5\u03b2-carboxymethyl-3\u03b1-hydroxy-2\u03b2-hydroxymethyl-1-methylpryrroli-dine (83) and 2\u03b1-carboxymethyl-5\u03b1-dimethyla ino-4\u03b1-hydroxy-tetrahydrpyran (84) (Fi-gure 7) [52]. Po yhydroxyalkaloids such as rimethy silyl (TMS) derivatives of \u03b1-homonojirimycin were isolated from S. gaultheriifolia Radcl.-Sm leaves and S. adenophora leaf fragment [55]. N+OHOHO\u2013ONOHOHOHO OHO NCOOH82 83 84HH Figure 7. Structures of alkaloids isolated from S. glomerulata. 4.8. Flavonoids Flavone-type flavonoids have been isolated from Suregada species [56]. Flavone gly-cosides, gelomuloside A (85) and B (86); flavone glycoside, 7,4\u2019-O-L-ramnopyranosyl (12)-D-glucopyranoside (87) (Figure 8), resulted from the investigation of seeds of S. multiflora. Three other flavones were obtained from the isolation of the leaves of S. multiflora, namely, kanugin (88), dimethoxy kanugin (89), and pinnatin (90) (Figure 8) [57]. Das and Chakravarthy reported the isolation of a flavone glycoside, luteolin-7,4\u2032-dimethyl ether 3\u2032-glucoside (91) from the S. multiflora leaf extract (Figure 9) [57,58]. OOOOH OOOOOOH OOOOOOOOOO OOOO858688 89 90OOOHOHOHOHOOHOHOOOHOOHOH OHHOHOOOOOO Figure 8. Structures of flavones isolated from S. multiflora. Figure 7. Structures of alkaloids isolated from S. glomerulata.4.8. FlavonoidsFlavone-type flavonoids have been isolated from Suregada species [56]. Flavone gly-cosides, gelomuloside A (85) and B (86); flavone glycoside, 7,4\u2019-O-L-ramnopyranosyl(12)-D-glucopyranoside (87) (Figure 8), resulted from the investigation of seeds of S. multi-flora. Three other flavones were obtained from the isolation of the leaves of S. multiflora,namely, kanugin (88), dimethoxy kanugin (89), and pinnatin (90) (Figure 8) [57]. Das ndChakravarthy reported the isolation of a flavone glycoside, luteolin-7,4\u2032-dimethyl ether3\u2032-glucoside (91) from the S. multiflora leaf extract (Figure 9) [57,58].Pharmaceuticals 2023, 16, x FOR PEER REVIEW 16 of 30 4.6. Fatty Alcohol, Steroidal Glycoside and Phytosterol n-Octacosanol (79), \u03b2-sitosterol-3-\u03b2-D-glucopyranoside (80), and \u03b2-sitosterol (81) were isolated from S. angustifolia stem bark [9]. 4.7. Alkaloids Yan et al. explored S. glomerulata leaves (Blume) Baill., which afforded three pyrroli-dine alkaloids, namely 5\u03b2-carboxymethyl-3\u03b1-hydroxy-2\u03b2-hydroxymethyl-1,1-dimethyl-pryrrolidine (82), 5\u03b2-carboxymethyl-3\u03b1-hydroxy-2\u03b2-hydroxymethyl-1-methylpryrroli-i e (83) and 2\u03b1-carbo t l-5\u03b1-dimethylamino-4\u03b1-hydroxy-tetrahydrp ran (84) (Fi-re 7) [52]. Polyhydrox alkaloids such a trimethylsil (TMS) d rivatives of \u03b1-homonojirimycin were iso ted from S. gaultheriifolia Radcl.-Sm leaves and S. adenophora leaf fragment [55]. N+OHOHO\u2013ONOHOHOHO OHO NCOOH82 83 84HH Figure 7. Structures of alkaloids isolated from S. glomerulata. 4.8. Flavonoids Flavone-type flavonoids have been isolated from Suregada species [56]. Flavone gly-cosides, gelomuloside A (85) and B (86); flavone glycoside, 7,4\u2019-O-L-ramnopyranosyl (12)-D-glucopyranoside (87) (Figure 8), resulted from the investigation of seeds of S. multiflora. Three other flavones were obtained from the isolati n of the leaves of S. multiflora, namely, k nugin (88), dimethoxy kanugi (89), and pin atin (90) ( igure 8) [57]. Das and t rted the isolation of a avone glycoside, luteolin-7,4\u2032-dimethyl ether 3\u2032-glucoside (91) from the S. multiflora leaf re 9) [57,58]. OOOOH OOOOOOH OOOOOOOOOO OOOO858688 89 90OOOHOHOHOHOOHOHOOOHOOHOH OHHOHOOOOOO Figure 8. Structures of flavones isolated from S. multiflora. Figure 8. Structures of flavones isolated from S. multiflora.Pharmaceuticals 2023, 16, 1390 15 of 28ar ace ticals 2023, 16, x FOR PEER REVIEW 17 f 30 Figure 9. Structures of lignans isolated from S. multiflora. 4.9. Lignans Gondal and Choudhary isolated two lignans, pinoresinol (92) and syringaresinol (93), from the methanol extract of leaves of S. multiflora (Figure 9) [15,47]. 4.10. Amino Acids The leaves of S. glomerulata were investigated and afforded twelve amino acids, namely, alanine (94), glutamic acid (95), leucine (96), isoleucine (97), proline (98), \u03b3-ami-nobutyric acid (99), (R)-carnitine (100), lysine (101 (Figure 10) [53]. OHNHO98HONH2O99N+H3CH3C CH3 OH OO\u2013100OHONH2H2N10195HO OHO ONH2 Figure 10. Structures of amino acids isolated from S. glomerulata. 4.11. Pyrimidines, Purine Nucleoside and Pyridines Uracil (102), uridine (103), guanosine (104), and 3H-imidazo [4,5-c]pyridine (105) (Figure 11) were isolated from The leaves of S. glomerulata [53]. NHNHOO102NNHOOOHOHO OH103NNNH105104NOHOHO OHNNHNONH2 Figure 11. Structures of pyrimidines, purine nucleoside, and pyridines isolated from S. glomerulata. 4.12. Pyrrolidine-Type Iminosugars The water extract of Suregada glomerulata leaves afforded ten pyrrolidine-type imino-sugars, namely: 7-deoxy-homoDMDP (106), 6-deoxy-homoDMDP (107), 2,5-imino-2,5,6-trideoxy-D-gulo-heptitol (108), 2,5-imino-2,4,5-trideoxy-D-manno-heptitol (109), 2,5-imino-2,4,5-trideoxy-D-gulo-heptitol (110), 2,5-imino-2,4,5,6-tetradeoxy-D-gulo-heptitol OOOOHOOHOO93 92OOOOHHOOHHHHFigure 9. Structures of lignans isolated from S. multiflora.4.9. LignansGondal and Choudhary isolated two lignans, pinoresinol (92) and syringaresinol (93),from the methanol extract of leaves of S. multiflora (Figure 9) [15,47].4.10. Amino AcidsThe leaves of S. glomerulata were investigated and afforded twelve amino acids, namely,alanine (94), glutamic acid (95), leucine (96), isoleucine (97), proline (98), \u03b3-aminobutyricacid (99), (R)-carnitine (100), lysine (101 (Figure 10) [53].Pharmaceuticals 2023, 16, x FOR PEER REVIEW 17 of 30 Figure 9. Structures of lignans isolated from S. multiflora. 4.9. Lignans Gondal and Choudhary isolated two lignans, pinoresinol (92) and syringaresinol (93), fr m the methanol extract of leaves of S. multiflora (Figure 9) [15,47]. . . i ci s leaves of S. glomerulata were investigate and afford d twelve mino cids, namely, alanine (94), glutamic acid (95), leuc ne (96), isoleucine (97), proline (98), \u03b3-am -obutyric acid (99), (R)-carnitine (100), lys ne (101 (Figure 10) [53]. OHNHO98HONH2O99N+H3CH3C CH3 OH OO\u2013100OHONH2H2N10195HO OHO ONH2 Figure 10. Structures of amino acids isolated from S. glomerulata. 4.11. Pyrimidines, Purine Nucleoside and Pyridines Uracil (102), uridine (103), guanosine (104), and 3H-imidazo [4,5-c]pyridine (105) (Figure 11) were isolated from The leaves of S. glomerulata [53]. NHNHOO102NNHOOOHOHO OH103NNNH105104NOHOHO OHNNHNONH2 Figure 11. Structures of pyrimidines, purine nucleoside, and pyridines isolated from S. glomerulata. 4.12. Pyrrolidine-Type Iminosugars The water extract of Sure da glomerulata leaves afforded ten pyrrolidine-type imino-sugars, namely: 7-deoxy-homoDMDP (106), 6-deoxy-h moDMDP (107), 2,5-imino-2,5,6-trideoxy-D-gulo-heptitol (108), 2,5-imino-2,4,5-trideoxy-D-manno-heptitol (109), 2,5-imin -2,4,5-trideoxy-D-gulo-heptitol (110), 2,5-imino-2,4,5,6-tetradeoxy-D-gulo-heptitol OOOOHOOHOO93 92OOOOHHOOHHHHFigure 10. Structures of amino acids isolated from S. glomerulata.4.11. Pyrimidines, Purine Nucleoside and PyridinesUracil (102), ridine (103), guanosine (104), and 3H-imidazo [4,5-c]pyridine (105)(Figure 11) were isolated from The leaves of S. glomerulata [53].Pharmaceuticals 2023, 16, x FOR PEER REVIEW 17 of 30 Figure 9. Structures of lignans isolated from S. multiflora. 4.9. Lignans Gondal and Choudhary isolated two lignans, pinoresinol (92) and syringaresinol (93), fr m the methanol extract of leaves of S. multiflora (Figure 9) [15,47]. 4.10. Amino Acids The leaves of S. glomerulata were investigated and afforded twelve amino acids, namely, alanine (94), glutamic acid (95), leucine (96), isoleucine (97), proline (98), \u03b3-ami-obut ric cid (9 ), (R)-carnitine (100), lysine (101 (Figure 10) [53]. OHNHO98HONH2O99N+H3CH3C CH3 OH OO\u2013100OHONH2H2N10195HO OHO ONH2 Figure 10. Structures of amino acids isolated from S. glomerulata. i i l f . l er l t [ ]. NHNHOO102NNHOOOHOHO OH103NNNH105104NOHOHO OHNNHNONH2 Figure 11. Structures of pyrimidines, purine nucleoside, and pyridines isolated from S. glomerulata. 4.12. Pyrrolidine-Type Iminosugars The water extract of Suregada glomerulata leaves afforded ten pyrrolidine-type imino-sugars, namely: 7-d oxy-homoDMDP (106), 6-deoxy-h moDMDP (107), 2,5-imino-2,5,6-trideoxy-D-gulo-heptitol (108), 2,5-imino-2,4,5-trideoxy-D-manno-heptitol (109), 2,5-imin -2,4,5-trideoxy-D-gulo-heptitol (110), 2,5-imino-2,4,5,6-tetradeoxy-D-gulo-heptitol OOOOHOOHOO93 92OOOOHHOOHHHHFigure 11. Structures of pyrimidines, purine nucleoside, and pyridines isolated from S. glomerulata.4.12. Pyrrolidine-Type IminosugarsThe water extract of S regada glomerulata leaves afforded ten pyrrolidine-type imi-nosugars, namely: 7-deoxy-homoDMDP (106), 6-deoxy-homoDMDP (107), 2,5-imino-2,5,6-trideoxy-D-gulo-heptitol (108), 2,5-imino-2,4,5-trideoxy-D-manno-heptitol (109), 2,5-imino-2,4,5-trideoxy-D-gulo-heptitol (110), 2,5-imino-2,4,5,6-tetradeoxy-D-gulo-heptitol (111),6-C-butyl-DMDP (112), 6-C-butyl-4-deoxy-DMDP (113), 6-C-(8-hydroxyoctyl)-DMDP (114)and 6-C-(8-hydroxyoctyl)-2,5-dideoxy-2,5-imino-D-galactitol (115) (Figure 12) [59].Pharmaceuticals 2023, 16, 1390 16 of 28Pharmaceuticals 2023, 16, x FOR PEER REVIEW 18 of 30 (111), 6-C-butyl-DMDP (112), 6-C-butyl-4-deoxy-DMDP (113), 6-C-(8-hydroxyoctyl)-DMDP (114) and 6-C-(8-hydroxyoctyl)-2,5-dideoxy-2,5-imino-D-galactitol (115) (Figure 12) [59]. HNH3CHO CH2OHOHHOHN CH2OHOHHOHOH2CHN CH2OHOHHOHOH2C106 107 108HNHOH2CHO CH2OHOH109HNn-C4H9HO CH2OHOHR112 R=OH113 R=HHNHOH2CHO CH2OHOH110HN CH2OHOHHOH2C1111147HN CH2OHOHHOHOHO1157HN CH2OHOHHOHOHO Figure 12. Structures of pyrrolidine-type iminosugars isolated from S. glomerulata. 5. Pharmacological Activities of the Suregada Genus The reviewed published article revealed that some of the isolated phytochemicals were tested for their pharmacological activities while some were not evaluated. Suregada species and some phytochemicals were screened for their antileishmanial, antidiabetic, antioxidant, cytotoxic, anti-plasmodial, antimicrobial, and anticancer activity. A summary of some Suregada species activities is presented in Table 2. 5.1. Antibacterial and Antimicrobial Activity Venkatesan et al., reported the screening of methanol, chloroform, and hexane ex-tracts of S. angustifolia stem bark at various concentrations (20, 10, and 5 mg\u00b7mL\u22121) against twelve human pathogenic bacteria [9]. The maximum zone inhibition at 20 mg\u00b7mL\u22121 in chloroform extract was observed as Klebsiella pneumonia (37 mm), Staphylococcus aureus (32 mm), A. hydrophila (40 mm), and Escherichia coli (40 mm). In comparison, the observations at 10 mg\u00b7mL\u22121 were slightly different observed as E. coli (32 mm), K. pneumoniae (30 mm), S. aureus (25 mm), and A. hydrophila (33 mm) [9]. Hexane extract at 20 mg\u00b7mL\u22121 revealed inhibition against K. pneumonia (29 mm), A. hydrophila (30 mm), Proteus vulgaris (25 mm), V. parahaemolyticus (25 mm), V. vulnificus (25 mm) and V. cholera (25 mm). The methanol extract at 20 mg\u00b7mL\u22121 showed zone inhibition against S. aureus (32 mm), E. aerogenes (26 mm), E. coli (26 mm), and P. vulgaris (25 mm) [9]. Aqueous, chloroform, and ethanol extracts of S. angustifolia bark and leaves were screened against two bacterial strains (Gram-positive and negative) and two fungal strains using the disc diffusion method. The aqueous leaf extract revealed zone inhibition of Pseu-domonas aeruginosa (18.00 mm) and Bacillus subtillis (8.00 mm). The aqueous extract of S. angustifolia bark revealed zone inhibition of P. aeruginosa (20.00 mm) and B. subtillis (15.00 mm). The chloroform bark extract showed antibacterial properties against P. aeruginosa and B. subtilis with zone inhibition values of 18.00 mm and 15.00 mm. The ethanol leaf Figure 12. Structures of pyrrolidine-type iminosugars isolated from S. glomerulata.5. Pharmacological Activities of the Suregada GenusThe reviewed published article revealed that some of the isolated phytochemicalswere tested for their pharmacological activities while some were not evaluated. Suregadaspecies and some phytochemicals were screened for their antileishmanial, antidiabetic,antioxidant, cytotoxic, anti-plasmodial, antimicrobial, and anticancer activity. A summaryof some Suregada species activities is presented in Table 2.5.1. Antibacterial and Antimicrobial ActivityVenkatesan et al., reported the screening of methanol, chloroform, and hexane extractsof S. angustifolia stem bark at various concentrations (20, 10, and 5 mg\u00b7mL\u22121) against twelvehuman pathogenic bacteria [9]. The maximum zone inhibition at 20 mg\u00b7mL\u22121 in chloroformextract was observed as Klebsiella pneumonia (37 mm), Staphylococcus aureus (32 mm), A.hydrophila (40 mm), and Escherichia coli (40 mm). In comparison, the observations at10 mg\u00b7mL\u22121 were slightly different observed as E. coli (32 mm), K. pneumoniae (30 mm),S. aureus (25 mm), and A. hydrophila (33 mm) [9]. Hexane extract at 20 mg\u00b7mL\u22121 revealedinhibition against K. pneumonia (29 mm), A. hydrophila (30 mm), Proteus vulgaris (25 mm), V.parahaemolyticus (25 mm), V. vulnificus (25 mm) and V. cholera (25 mm). The methanol extractat 20 mg\u00b7mL\u22121 showed zone inhibition against S. aureus (32 mm), E. aerogenes (26 mm), E.coli (26 mm), and P. vulgaris (25 mm) [9].Aqueous, chloroform, and ethanol extracts of S. angustifolia bark and leaves werescreened against two bacterial strains (Gram-positive and negative) and two fungal strainsusing the disc diffusion method. The aqueous leaf extract revealed zone inhibition ofPseudomonas aeruginosa (18.00 mm) and Bacillus subtillis (8.00 mm). The aqueous extractof S. angustifolia bark revealed zone inhibition of P. aeruginosa (20.00 mm) and B. subtillis(15.00 mm). The chlorofor bark extract showed antibacterial properties against P. aerugi-nosa and B. subtilis with zone inhibition values of 18.00 mm and 15.00 mm. The ethanol leafextract revealed activity against P. aeruginosa, S. aureus, and B. subtilis with zone inhibitionvalues of 9.00 mm, 20.00 mm, and 12.00 mm, respectively [25].The antibacterial activity of S. multiflorum leaves, bark, and stem extracts was investi-gated. The leaves hexane extracts revealed partial zone inhibition against Mycobacteriumlacticola and S. aureus (10 to 11 mm). The hexane extract of S. multiflorum bark showed zoneinhibition of 10 mm against S. aureus. The leaf dichloromethane extracts partially showedzone inhibition of 10 mm against S. aureus, 0.5 mm against E. coli, and 11 mm against M.Pharmaceuticals 2023, 16, 1390 17 of 28lacticola and moderately revealed zone inhibition of 16 mm Bacillus subtilis [60]. The barkdichloromethane extracts showed a moderate zone inhibition of 12 to 13 mm, 15 mm, 13 to14 mm, and 12 to 13 mm against S. aureus, B. subtilis, M. lacticola, and Xanthomonas campestris,respectively. The stem hexane extract revealed partial inhibition against M. lacticola with azone inhibition value of 11 mm. The stem-dichloromethane extracts showed partial zoneinhibition of 0.3 mm against E. coli and 3 mm against X. campestris and moderate inhibitionagainst S. aureus, B. subtilis, and M. lacticola with zone inhibition of 13 mm, 13 mm and18 mm, respectively [60]. The dichloromethane extract was the most active extract, followedby hexane and methanol extracts [60].The (1:9) methanol-ethyl acetate extract of S. multiflora leaves and root was inves-tigated against four gram-negative and five gram-positive bacterial strains at a dose of200 \u00b5g.disc-1. Suregada multiflora root extract revealed a promising antimicrobial effectagainst B. subtilis, Shigella boydii, E. coli, S. aureus, B. cereus, B. megatherium, B. anthracis, Shi.flexneri and P. aeruginosa with the zone inhibition values of 12 \u00b1 0.05 mm, 12 \u00b1 0.07 mm,13 \u00b1 0.01 mm, 12 \u00b1 0.07 mm, 11 \u00b1 0.13 mm, 10 \u00b1 0.22 mm, 11 \u00b1 0.02 mm, 10 \u00b1 0.01 mm,11 \u00b1 0.12 mm, and 9 \u00b1 0.05 mm, respectively, with E. coli being the highest [61]. The S.multiflora leaf extract showed mild potency when screened against B. subtilis, S. aureus, andShi. flexneri, E. coli, and Pseudomonas aeruginosa with the zone inhibition range of 5 \u00b1 0.05 to6 \u00b1 0.05 mm [62]. Since significant activity was observed in all the tested bacterial strainsfor the root extract, minimum inhibitory concentration (MIC) values were only applied tothe root extract. E. coli was the most sensitive, with a MIC of 0.625 mg/mL [61]. S. multifloraroot extract further revealed a maximum relative percentage inhibition against Shi. boydii(34.45%), B. subtilis (32.12%) and E. coli (41.23%) at 200 \u00b5g\u00b7mL\u22121 dose. The leaf extract of S.multiflora showed a relative percentage range between 11.21 and 14.53%, and the applieddosage was 200 \u00b5g\u00b7mL\u22121 [61].Helioscopinolide A (1) isolated from S. multiflora (1) showed an antibacterial effectagainst S. aureus 6538P (2.5 \u00b5g\u00b7spot\u22121) [62]. Epifriedelinol (75) isolated from S. multiflorawas previously screened against seven Gram-negative bacterial strains, namely, K. pneu-moniae, P. aeruginosa, Salmonella typhimurium, E. coli, and Shi. Flexneri, Proteus vulgaris, andShi. sonnei and five Gram-positive bacterial strains, namely B. subtilis, B. pumilus, B. cereus,Micrococcus luteus and S. aureus [59]. Epifriedelinol (75) revealed zone inhibition Grange of14.00 \u00b1 0.58 to 25.66 \u00b1 0.88 mm against all the Gram-positive and negative bacterial strainswith the MIC range of 6.25 and 50 \u00b5g\u00b7mL\u22121 and the minimum bactericidal concentration(MBC) range of 12.5 and 100 \u00b5g\u00b7mL\u22121. Epifriedelinol (75) was the most sensitive againstS. aureus, with a zone inhibition of 25.66 \u00b1 0.58 mm. MBC of 12.5 \u00b5g\u00b7mL\u22121 and MIC of6.25 \u00b5g\u00b7mL\u22121. Epifriedelinol (75) revealed lower activity against K. pneumoniae with a zoneinhibition value of 14 \u00b1 0.88 mm. MBC of 100 \u00b5g\u00b7mL\u22121 and MIC of 50 \u00b5g\u00b7mL\u22121 [60,63].5.2. Insecticidal ActivityThe (1:9) methanol: ethyl acetate extract of S. multiflora root revealed a 100% mortalityrate for Tribolium castaneum at 50 mg\u00b7mL\u22121 dose in 12 h, while leaves extract revealed amortality rate of 40% for Tribolium castaneum at 50 mg\u00b7mL\u22121 dose in 48 h. Strong insecticidalactivity was observed on the S. multiflora root extract. A dose-dependent manner wascarried out, where five graded doses, namely, 5, 10, 20, 30, and 40 \u00b5g\u00b7mL\u22121 were utilized,and the mortality rate was 33.33%, 53.33, 86.66, 93.33, and 100, respectively [61].5.3. Antifungal ActivityJahan et al. stated that Suregadolide A (4) isolated from S. multiflora revealed an anti-fungal effect of minimum concentration that produces zone inhibition of 12 mm diameter(IC12) of 70 and 35 \u00b5g\u00b7mL\u22121 in the RAD+ and RAD52 mutant yeast assays, respectively [34].5.4. Anticancer ActivityIn 2008, Lee et al. published that the dichloromethane extract of S. aequoreum wasactive against several human cancer cells with IC50 < 20 \u00b5g\u00b7mL\u22121 [36]. Yan et al. statedPharmaceuticals 2023, 16, 1390 18 of 28that S. glomerulata roots were tested against five tumor human cancer cells, namely, livercancer (Bel 7402), ovarian (A2780), lung cancer (A549), stomach (BGC 823) and colon(HCT-8) and showed weak cytotoxic effects against all the cancer cells [54]. S. zanzibariensisstem bark (1:1) dichloromethane-methanol extract was screened at 100 \u00b5g\u00b7mL\u22121 dose toevaluate anticancer properties against melanoma (UAC62), breast (MCF7) and cells renal(TK10). The (1:1) dichloromethane-methanol extract was potent against TK10, UACC62 andMCF7 cancer cells with the Total Growth Inhibition (TGI) of 0.60 \u00b5g\u00b7mL\u22121, 0.54 \u00b5g\u00b7mL\u22121and 5.27 \u00b5g\u00b7mL\u22121, respectively, and 50% Growth Inhibition (GI50) of 0.25 \u00b5g\u00b7mL\u22121 forUACC62, 0.26 \u00b5g\u00b7mL\u22121 for TK10 and 0.81 \u00b5g\u00b7mL\u22121 for MCF7 [51]. Helioscopinolide A(1) was potent against breast adenocarcinoma (MCF-7) and lung cancer (NCI-H460) withGI50 of 67.50 \u00b1 3.04 \u00b5M and 72.78 \u00b1 6.33 \u00b5M [64] and inhibited anticancer activity againsthuman cervical carcinoma (HeLa) (IC50 = 0.11 \u00b5M) and breast cancer (MDA MB-231)(IC50 = 2.1 \u00b5M) cells [65]. Gelomulide E (12) isolated from S. multiflora was potent at aconcentration of 5x10-5 M against the lung (NCI H490) cancer cell with growth inhibitionof more than 85% [62]. Gelomulide E (12) was screened in a panel of 60 tumor cells and wasreported to show activity against leukemia (CCRF-CEM), leukemia (SR), leukemia (K-562),breast (MD MB-435), and colon (HTC-15) with more than 95% growth inhibition [56].Gelomulide K (19) and M (20) isolated from S. aequorea afforded moderate cytotoxicityactivities against breast (MCF7 and MB-231), liver (HepG2), and lung (A549) with the IC50range of 10.5 to 29.8 \u00b5M [35]. Gelomulide K (19) suppressed the growth of breast cancercells, such as MDA-MB-231, BT474, MCF-7, MDA-MB-468 and SKBR3, with the IC50 rangeof 25.30 to 37.84 \u00b5mol\u00b7L\u22121 [49]. Mangiolide (34) isolated from S. zanzibariensis exhibitedanticancer activities with TGI values of 0.02 \u00b5g\u00b7mL\u22121 (TK10), 0.03 \u00b5g\u00b7mL\u22121 (UACC62) and0.05 \u00b5g\u00b7mL\u22121 (MCF7) and the GI50 values 0.07 \u00b5g\u00b7mL\u22121 (TK10); 0.06 \u00b5g\u00b7mL\u22121 (UACC62)and 0.33 \u00b5g\u00b7mL\u22121 (MCF7). Jolkinolide B (35) isolated from S. zanzibariensis showed anti-cancer properties with the TGI of 13.99, 5.03 and 62.03 \u00b5g\u00b7mL\u22121 against TK10, UACC62and MCF7 cancer cells, respectively, and GI50 values of 0.94 \u00b5g\u00b7mL\u22121 for UACC62, 3.31\u00b5g\u00b7mL\u22121 for TK10 and 2.99 \u00b5g\u00b7mL\u22121 for MCF7 and further exhibited selectivity againstmelanoma (UACC62) [50].Jolkinolide B (35) reduced the production of lactic acid and ATP and induced tumorcell apoptosis in mouse melanoma B16F10 cells. Jolkinolide B (35) showed a low level ofthe mRNA expression of glycolysis-related kinase genes (Ldha and Hk2) in B16F10 cellsand glucose transporter genes (Glut1, Glut3, and Glut4) [66\u201368]. Jolkinolide B (35) showedan increased level of the mRNA expression of pro-apoptosis genes (Bax) and reduced therate of the mRNA expression of anti-apoptosis genes (Caspase-3, Caspase-9, and Bcl-2)which confirms its anticancer effect. It improved reactive oxygen species (ROS) levels inB16F10 cells and reduced the mitochondrial membrane potential [65\u201367]. Jolkinolide B(35) was reported to induce the tumor apoptosis of murine melanoma B16F10 cells in amouse xenograft model and suppress tumor growth. Jolkinolide B (35) induced apoptosisviability and decreased cells in a time- and dose-dependent manner in human leukemic(U937) [62]. Jolkinolide B (35) decreased the colony formation and cell viability of HT29,CRC, and SW620 cells [65\u201367]. Jolkinolide B (35) showed phosphorylation of extracellularsignal-regulated kinase (ERK) [68]. According to Luo et al., Jolkinolide B (35) showed thelinkage of MDA MB 231 cells to fibronectin [68]. Jolkinolide B (35) reduced the proliferationof three human cancer cells, namely, oesophageal carcinoma (Aca-109), chronic myeloidleukemia (K562), and hepatoma (HepG2), with the IC50 of 23.7 \u00b5g\u00b7mL-1, 12.1 \u00b5g\u00b7mL\u22121 and>50.0 \u00b5g\u00b7mL\u22121, respectively [69]. 6\u03b2-acetoxy-2-ene-1-one-8\u03b2,14\u03b2-epoxy-13,15-abiatene-16,12-olide (56) demonstrated promising anticancer effect against the lung (NCI-H460)cell with 85% growth inhibition at 5 \u00d7 10\u22125 M. Compound (56) further activity againstLeukemia (SR, CCRF-CEM and K-562), Breast (MD-MB-435) and Colon (HCT-15) and withover 95% growth inhibition [15].Bauerenol (74) exhibited apoptosis-inducing potential against HepG2 cancer cells andgrowth-inhibitory effects. Bauerenol (74) inhibited the proliferation of retinoblastoma cellsPharmaceuticals 2023, 16, 1390 19 of 28(SO-Rb50), with the IC50 of 10 \u00b5M (p < 0.05). Furthermore, bauerenol (74) suppressed theinvasion and movement of SO-RB50 cells by (p < 0.05) [70].5.5. Antinociceptive ActivitySimiarenol (81) isolated from S. zanzibariensis exhibited a noticeable antinociceptiveeffect with the 50% infectious dose (ID50) of 18.87 (14.6\u201324.4) mmol\u00b7kg\u22121. These results weremore active compared to other reference drugs, such as dipyrone and aspirin, which areknown as anti-inflammatory and analgesic drugs, with an ID50 of 133 and 162 mmol\u00b7kg-1,respectively [71,72].5.6. Antidiabetic ActivityThe water extract of S. glomerulata leaves revealed an inhibitory effect against \u03b1-glucosidase with the IC50 2.29 \u00b5g\u00b7mL\u22121 [53].5.7. Antiviral ActivitySuregada multiflora revealed the presence of anti-human immunodeficiency virus-1(HIV 1) protein, glycosylation-associated protein (GAP3), and displayed an inhibitory effecton the replication and infection of anti-HIV activity, and herpes simplex virus (HSV) [15,73].S. zanzibariensis leaf extract revealed toxicity against herpes simplex virus 2 (HSV-2) withthe IC50 of 11.5 \u00b5g\u00b7mL\u22121 and toxic on African green monkey kidney cells (GMK AH1) withthe CC50 52 \u00b5g\u00b7mL\u22121. Zanzibariolides A (58) and B (59) and simiarenol (81) exhibited noanti-HSV-2 effect and displayed minor toxicity against GMK AH1 cells at \u2265100 \u00b5M [45].5.8. CytotoxicityThe dichloromethane-methanol crude extract of S. multiflorum revealed promising cy-totoxicity against 60-cell tumour panels conducted at the NCI [16]. According to Kigonduaet al., the ethyl acetate extract of S. multiflorum stem was cytotoxic against the cancer cell(MDA-MB435) [74]. Ethanol extract of the S. multiflorum bark revealed cytotoxicity againstcervical cancer (Hela cells). The leaves aqueous and methanol extracts of S. zanziberiensisrevealed low toxicity towards human embryonic lung fibroblast (HELF) cells with a 50%cytotoxic concentration (CC50) of >20 \u00b5g\u00b7mL\u22121 [74].Luo et al. reported that Jolkinolide B (35) revealed weak cytotoxicity against fivehuman cancer cells, namely, Bel 7402, A549, (BGC 823), HCT-8, and A2780 with the IC50 of5.95, 6.10, 5.84, 6,88, and 5.09 \u00b5g\u00b7mL\u22121, respectively [70]. 3-oxo-jolkinolide B (44) showeda moderate cytotoxic effect against HCT-8, A549, BGC 823, Bel 7402, and A2780 with theIC50 of 6,77, 8.03, 10, 7.20, and 6.81 \u00b5g\u00b7mL\u22121, respectively [64]. The treatment of HepG2cells with bauerenol (74) reduced the growth significantly with a 50% growth inhibitoryconcentration of 25 \u00b5g\u00b7mL\u22121 [75].5.9. Anti-InflammatoryThe stem bark of S. multiflora showed anti-inflammatory activity against lipopolysac-charide (LPS)-induced nitric oxide (NO) and prostaglandin E(2) (PGE(2)) releases inRAW264.7 cells [17]. Helioscopinolide A (1) was the most active compound against NOrelease with an IC50 of 9.1 \u00b5M than helioscopinolide C (2) with an IC50 of 24.5 \u00b5M [17].5.10. AntioxidantThe antioxidant activities of helioscopinolide A (1) inhibited COX 2 and iNOS mRNA [17].5.11. Anti-Allergic ActivityHelioscopinolide A (1), helioscopinolide C (2), and helioscopinolide I (3) exhibitedsignificant anti-allergic effects towards antigen-induced \u03b2-hexosaminidase release withthe IC50 of 26.5, 37.0 and 29.3 \u00b5M, respectively [33]. Ent-16-kauren-3\u03b2,15\u03b2,18-triol (60),ent-3-oxo-16-kauren-15\u03b2,18-diol (61), ent-16-kaurene-3\u03b2,15\u03b2-diol (62) and abbeokutone (63)Pharmaceuticals 2023, 16, 1390 20 of 28revealed noticeable anti-allergic effect against antigen-induced \u03b2 hexosaminidase releasewith the IC50 of 22.5, 22.9 28,7 and 42.1 \u00b5M, respectively [36].5.12. Antileishmanial ActivityThe aqueous extract of S. zanzibariensis leaves revealed anti-leishmanial activity whentested on Leishmania major promastigotes with a mortality percentage of 40.5 \u00b1 1.99%.The methanol extract revealed good anti-leishmanial activity on Leishmania major amastig-otes with a mortality percentage of 28.0 \u00b1 2.11%. Nitrogen production macrophagesinfected with amastigotes of Leishmania major treated with the S. zanzibariensis aqueousand methanol extracts showed significant Nitric oxide concentrations at 4.0 \u00b1 0.56 and6.6 \u00b1 0.63 \u00b5g\u00b7mL\u22121 at 1000 \u00b5g\u00b7mL\u22121 [74]. The ethanol extract of S. procera revealed goodantileishmanial activity with the IC50 of \u226410 \u00b5g\u00b7mL\u22121 [76]. Gelomulide A (6) and G (12)displayed significant antileishmanial activity with the IC50 below 20 \u00b5g\u00b7mL\u22121 [47].5.13. Antiplasmodial ActivityMethanol extract of S. zanzibariensis exhibited a good antiplasmodial effect againstPlasmodium falciparum strains with the IC50 of 4.66 \u00b1 0.22 \u00b5g\u00b7mL\u22121 chloroquine-resistant(W2) and 1.82 \u00b1 0.07 \u00b5g\u00b7mL\u22121 chloroquine-sensitive (D6) [77]. Omulokoli et al. stated thatS. zanzibariensis leaf extract revealed significant antiplasmodial activity with the IC50 of1.5 \u00b5g\u00b7mL\u22121 against Plasmodium falciparum chloroquine-resistant (ENT36) and chloroquine-sensitive (K67) [77].Table 2. Pharmacological activities of the Suregada genus.Plant Species Plant Part Extract Activity Effect ReferencesS. aequorea Unspecified Dichloromethane AnticancerExhibited activity against differenthuman cancer cells with the IC50 of<20 \u00b5g\u00b7mL\u22121.[35]S. angustifolia Stem barkMethanolAntibacterialRevealed zone inhibition of S. aureus(32 mm), Enterobacter aerogenes(26 mm), E. coli (26 mm), and P. vulgaris(25 mm) at 20 mg\u00b7mL\u22121.[9]ChloroformShowed zone inhibition of A. hydrophila(40 mm), K. pneumonia (37 mm), S.Aureus (32 mm), and E. coli (40 mm) at20 mg\u00b7mL\u22121.HexaneExhibited zone inhibition of A.hydrophila (29 mm), K. pneumonia(29 mm), P. vulgaris (25 mm), V. vulnificus(25 mm), V. parahaemolyticus (25 mm), V.cholera (25 mm) at 20 mg\u00b7mL\u22121.S. glomerulata Leaves Water Antidiabetic Potent inhibition against \u03b1-glucosidasewith the IC50 of 2.29 \u00b5g\u00b7mL\u22121.[49]S. multifloraRootsMethanol: Ethylacetate (1:9)Insecticidal activityRevealed 100% mortality rate ofTribolium castaneum[61]LeavesShowed a 40% mortality rate ofTribolium castaneumAntibacterial andAntimicrobialRevealed mild activity against E. coli, Sh.Flexneri, B. subtilis, S. aureus, and P.aeruginosa with the of zone inhibitionrange of 5 \u00b1 0.10 to 6 \u00b1 0.13 mm.[7]RootsExhibited significant activity against E.coli with zone inhibition of13 \u00b1 0.01 mm and MIC of0.625 mg\u00b7mL\u22121.[61]Stem bark Unspecified InflammatoryactivityExhibited NO inhibitory effect with theIC50 of 8.6 \u00b5g\u00b7mL\u22121.[17]Pharmaceuticals 2023, 16, 1390 21 of 28Table 2. Cont.Plant Species Plant Part Extract Activity Effect ReferencesS. procera Unspecified Ethanol Anti-leishmanialactivityExhibited strong activity,IC50 value \u2264 10 \u00b5g\u00b7mL\u22121[76]S. zanzibariensisLeavesMethanolAnti-plasmodialactivityRevealed good anti-plasmodialproperties against Plasmodium falciparumstrains (W2 and D6) with IC50 of4.66 \u00b1 0.22 \u00b5g\u00b7mL\u22121 and1.82 \u00b1 0.07 \u00b5g\u00b7mL\u22121.[74]Showed anti-plasmodial activity(1.5 \u00b5g\u00b7mL\u22121) against Plasmodiumfalciparum ENT36 and K67 with the IC50of 1.5 \u00b5g\u00b7mL\u22121.[71]Aqueous extractAnti-leishmanialactivityRevealed anti-leishmanial activity onLeishmanial major promastigotes andamastigotes with a mortality percentageof 40.5 \u00b1 1.99%.[74]Methanol extractsPossessed good anti-leishmanial activityon Leishmania major amastigotes with amortality percentage of 28.0 \u00b1 2.11%.Revealed substantial differences in theproduction of NO by macrophagesinfected with Leishmania majoramastigotes (6.6 \u00b1 0.63 \u00b5M).Aqueous extractsShowed a significant difference in theproduction of nitric oxide bymacrophages infected with Leishmaniamajor amastigotes (4.0 \u00b1 0.56 \u00b5M).In vitro cytotoxicityLow toxicity was observed againstHELF cells with a cytotoxicconcentration of 50% (CC50)value > 20 \u00b5g\u00b7mL\u22121.Methanol extracts Showed low toxicity against HELF cellswith the CC50 > 20 \u00b5g\u00b7mL\u22121.[78]Stem bark Dichloromethane/methanol AnticancerShowed potent anticancer activityagainst TK10 with the TGI and GI50 of0.60 \u00b5g\u00b7mL\u22121 and 0.26 \u00b5g\u00b7mL\u22121.[50]Revealed anticancer activity againstUACC62 with the TGI and GI500.54 \u00b5g\u00b7mL\u22121 for and 0.25 \u00b5g\u00b7mL\u22121.[50]Showed anticancer activity againstMCF7 with the TGI and GI505.27 \u00b5g\u00b7mL\u22121 and 0.81 \u00b5g\u00b7mL\u22121.6. Comparison of Ethnomedicinal Uses with the Pharmacological UsesSeveral plant species of the Suregada genus are utilized by locals in traditional medicineagainst various ailments such as headaches and colds, dysentery, malaria, placenta apposi-tion, epilepsy, skin diseases, worms, weakness, blood vomiting, piles, toothache, eczema,venereal diseases, pyrexia, lymphatic disorders, hepatitis, fungal infection, leprosy, fever,poisonous effects, stomach disorder, squint eye, gum disease, asthma, dysentery, vaginalcandidiasis, abdominal pains, wound healing and ankylostomiasis and also as purgative,an astringent and against snakebite. Pharmacological studies were conducted on variousspecies of this genus, such as anti-inflammatory, anticancer, antiviral, antidiabetic, antimi-crobial, antileishmanial, antiplasmodial, cytotoxic, antioxidant, and insecticidal activity.A comparison of traditional medicinal uses of genus Suregada with the pharmacologicalstudies is described as follows:\u2022 The methanol and hexane extracts of S. anguistifolia, showed a maximum antibacterialeffect against E. coli, A. hydrophila, and K. pneumonia. A similar activity was observedPharmaceuticals 2023, 16, 1390 22 of 28in S. aureus in chloroform and methanol extracts of S. anguistifolia stem bark. Staphylo-coccus aureus bacteria cause toothache and skin infections [9]. The pharmacologicalresults from this plant species support the claims of traditional medicinal uses ofS. anguistifolia, where Indian people in Kanis utilize it to treat skin infections andtoothache [9].\u2022 The wood of S. multiflora was reported to treat pyrexia, eczema, and venereal diseases,and the roots are utilized to treat lymphatic disorders and skin infections [17]. InThailand, S. multiflora is utilized to treat skin diseases and inflammation [17]. Varioussolvent extracts from S. multliflora were screened for antibacterial and antimicrobialactivity and exhibited effects against B. subtilis, P. aeruginosa, Shi. flexineri, S. aureus,and E. coli [62]. S. aureus is responsible for skin infections, gum diseases, eczema,and pyrexia (fever). The bacteria P. aeruginosa is responsible for lymphatic disorders,which can include swelling. E. coli and shi. flexineri responsible for pyrexia (fever) [76].Helioscopinolide A (1) and epifriedelinol (75) isolated from S. multiflora revealed an-tibacterial activity that further substantiates the traditional uses claims of S. multiflora.Epifriedelinol (75) exhibited the highest zone inhibition against S. aureus. S. aureus isthe bacteria responsible for skin infection, eczema, and gum diseases [57,59,71]. Sure-gadolide (4) isolated from S. multiflora showed antifungal activity, which confirms theclaims of the traditional uses of the plant being utilized for treating fungal infectionsand skin disease [34].\u2022 In some regions, the granule products of this species can be prepared, which actsas a powerful organic herbicide [19]. When tested for insecticidal activity, the (1:9)methanol: ethyl acetate root extract of S. multiflora revealed a mortality rate of 100% forTribolium castaneum at 50 mg\u00b7mL\u22121 dose in 12 h [61]. Furthermore, the dichloromethaneextract of S. multiflora stem showed partial antibacterial activity with zone inhibition of3 mm against X. campestris [55]. S. multiflora revealed an antibacterial activity againstX. campestris, which is responsible for plant diseases and insecticidal activity, whichconfirms the claims that the granules of S. multiflora act as organic herbicide [55,78].\u2022 In Thailand, S. multiflora is used to treat inflammation [18]. The stem bark of S.multiflora showed anti-inflammatory properties against lipopolysaccharide (LPS)-induced nitric oxide (NO) and prostaglandin E (2) (PGE(2)) releases in RAW264.7 cells,and the anti-inflammatory mechanism on mRNA expression was carried out [17].\u2022 A mixture of S. multiflorum is mixed with other herbs it is used as an anticancerrecipe [17]. Helioscopinolide A (5) and gelomulide E (12) isolated from S. multi-flora showed anticancer activity against various types of cancer, namely, leukemia(CCRF CEM), leukemia (SR), leukemia (K-562), breast (MD-MB-435), and colon (HTC-15) which supports the claims of S. multiflora being used traditionally in the anti-cancer recipe.\u2022 S. zanzibariensis leaves are utilized to treat malaria. The leaf extract of S. zanzibariensisrevealed high anti-plasmodial activity with the IC50 value of1.5 \u00b5g\u00b7mL\u22121) againstPlasmodium falciparum K67 and ENT36 [77].\u2022 Giriama and Duruma people use a root decoction to treat body swelling [28]. Tan-zanian people used the stem bark and root extract of S. zanzibariensis to treat anky-lostomiasis caused by parasitic hookworms [25]. Nitrogen production macrophagesinfected with amastigotes of Leishmania major treated with the methanol and aqueousextracts of S. zanzibariensis showed significant Nitric oxide concentration at 4.0 \u00b1 0.56and 6.6 \u00b1 0.63 \u00b5g\u00b7mL\u22121 at 1000 \u00b5g\u00b7mL\u22121 [74]. The potent activity of this speciesagainst Leishmania, a parasitic disease, supports the claim that S. zanzibariensis isused to treat ankylostomiasis and body swelling. Simiarenol (81) isolated from S.zanzibariensis exhibited noticeable antinociceptive properties with the ID50 of 18.87(14.6\u201324.4) mmol\u00b7kg\u22121 [71,72]. The activity of Simiarenol validates the claims of S.zanziberiensis being traditionally used for chest and abdominal pains.Pharmaceuticals 2023, 16, 1390 23 of 287. ConclusionsThe objective of this review was to outline the previous findings on the genus Sure-gada focusing on phytochemicals, pharmacological activities, and medicinal uses of theextracts and phytochemicals isolated from Suregada the species. The results showed that thegenus Suregada is important due to its traditional medicinal benefits. This genus containscompounds that could be further explored for treating various ailments.The Suregada species are traditionally utilized in treating gum and hepatic diseases,mixed with other herbs, and used as an anticancer recipe to treat pyrexia, eczema, venerealdiseases, lymphatic disorder, skin infection, skin infections, toothache, ankylostomiasis,gonorrhea, and stomach-ache. Pharmacological studies revealed that the compounds in theSuregada species exhibit diverse biological activity, including antibacterial, antimicrobial,antiplasmodial, anticancer, and antiviral as in Figure 13.Pharmaceuticals 2023, 16, x FOR PEER REVIEW 26 of 30 traditional uses but ave not been investigated for their pharmacological uses and phyto-chemistry. Figure 13. Summary of the ethnomedicinal, phytochemistry, and pharmacological properties of Suregada species. The presence of biologically active tested phytochemicals in Suregada species could afford an important basis in the discovery of drugs. Moreover, most of the activities in-vestigated so far are in vitro testing, and no in vivo screenings were performed. The bio-chemical interaction through which the extracts and isolated compounds of Suregada pro-duce its pharmacological effects of displaying promising activities should be further in-vestigated. Author Contributions: Conceptualization, M.M.; methodology, M.M.; software, D.K.; validation, M.M., V.J.T. and M.C.; formal analysis, M.M.; investigation, M.M. and D.K.; resources, V.J.T.; data curation, M.C.; writing\u2014original draft preparation, M.M.; writing\u2014review and editing, M.M., O.G., M.K.L., R.N., G.F. C.T.; visualization, M.M.; supervision, V.J.T.; project administration, D.K.; fund-ing acquisition, V.J.T. All authors have read and agreed to the published version of the manuscript. Funding: The authors would like to thank the South African National Research Foundation (NRF) for the funding. The research for which this review article is supported by the NRF Thuthuka Grants UID: 117898 (Dr. V.J. Tembu) and UID: 117872 (Prof. C. Tarirai). Informed Consent Statement: Not applicable Data Availability Statement: Data sharing is not applicable. Conflicts of Interest: The authors declare that they have no known competing financial interests or personal relationships that could influence the work reported in this paper. Lists of Abbreviations A2780 Human ovarian cancer cell line Aca-109 Human oesophageal carcinoma cell line ATP Adenosine triphosphate Bax pro-apoptosis gene B16F10 Mouse melanoma cell line Bcl-2 Anti-apoptosis gene Bel 7402 Human liver cancer cell BGC 823 Human stomach cancer cell BT474 Breast cancer cell line CC50 50% cytotoxic concentration CCRF-CEM Human leukemic lymphoblast cell line COX-2 Cyclooxygenase-2 Traditional Uses\u2022 Gonorrhea,\u2022 Stomachache\u2022 Pneumonia\u2022 Hernia, chest pain\u2022 Chicken pox\u2022 PugativePhytochemicals\u2022 Diterpenoids.\u2022 Triterpenoids\u2022 Alkaloids\u2022 Flavonoids\u2022 Lignans\u2022 Amino acidsPharmacologicalProperties\u2022 Antibacterial\u2022 Antifungal\u2022 Anticancer\u2022 Insecticidal\u2022 Antinociceptive\u2022 Antidiabetic\u2022 Antivral\u2022 AntioxidantLink between medicinalUses and pharmacologicalpropertiesGenus Suregada\u2022 S. adenophora\u2022 S. angustifolia\u2022 S. boiviniana\u2022 S. decidua\u2022 S. angustifolia\u2022 S. lithoxyla\u2022 S. multiflora\u2022 S. procera\u2022 S. zanzibariensisFigure 13. Summary of the ethnomedicinal, phytochemistry, and pharmacological properties ofSuregada species.A significant number of investigations have been conducted on S. multiflora and S.zanzibariensis; nevertheless, other species have not been widely investigated. Suregadaspecies, mainly. S. multiflora and S. zanzibariensis are utilized traditionally in the treatmentof various illnesses. S. zanzibariensis root extract is drunk to treat gonorrhea, stomach che,pneumonia, hernia, chest pains, chicken pox, and as a pur ative. There is a need for furtherevalu ion of this species since the relationship between traditional and pharmacologicaluses is not clearly shown. The antimicrobial studies for S. zanzibariensis should be performedto substantiate the mentioned claims. Furthermore, S. zanzibariensis is tr ditionally used totreat vaginal candidiasis, which may be yeast or fungal infection; conducting antifungalcandida studies to substantiate the claims is needed. Suregada multiflorum is traditionallyused to treat venereal diseases and hepatitis. The antiviral activity of these plants andtheir phytochemicals should be studied. Future pharmacological and phytochemicalinvestigations of African Sur gada species should focus on other traditionally used andaccepted species, such as S. procera, which is used to treat hemorrhoids and gonorrhea. Theother six African sp cies are accepted species, but their traditional uses are not known,namely, S. africana, S. croizatiana, S. gossweileri, S. ivorense, S. lithoxylia, and S. occidentale.Other Suregada species (S. decidua, S. boiviniana, and S. adenophora) have known traditionaluses but have not been investigated for their pharmacological uses and phytochemistry.The presence of biologically active tested phytochemicals in Suregada species couldafford an important basis in the discovery of drugs. Moreover, most of the activities investi-gated so far are in vitro testing, and no in vivo screenings were performed. The biochemicalinteraction through which the extracts and isolated compounds of Suregada produce itspharmacological effects of displaying promising activities should be further investigated.Pharmaceuticals 2023, 16, 1390 24 of 28Author Contributions: Conceptualization, M.M.; methodology, M.M.; software, D.K.; validation,M.M., V.J.T. and M.C.; formal analysis, M.M.; investigation, M.M. and D.K.; resources, V.J.T.; datacuration, M.C.; writing\u2014original draft preparation, M.M.; writing\u2014review and editing, M.M.,O.G., M.K.L., R.N., G.F. and C.T.; visualization, M.M.; supervision, V.J.T.; project administration,D.K.; funding acquisition, V.J.T. All authors have read and agreed to the published version ofthe manuscript.Funding: The authors would like to thank the South African National Research Foundation (NRF)for the funding. The research for which this review article is supported by the NRF Thuthuka GrantsUID: 117898 (Dr. V.J. Tembu) and UID: 117872 (Prof. C. Tarirai).Informed Consent Statement: Not applicable.Data Availability Statement: Data sharing is not applicable.Conflicts of Interest: The authors declare that they have no known competing financial interest orpersonal relationship that could influence the work reported in this paper.Lists of AbbreviationsA2780 Human ovarian cancer cell lineAca-109 Human oesophageal carcinoma cell lineATP Adenosine triphosphateBax pro-apoptosis geneB16F10 Mouse melanoma cell lineBcl-2 Anti-apoptosis geneBel 7402 Human liver cancer cellBGC 823 Human stomach cancer cellBT474 Breast cancer cell lineCC50 50% cytotoxic concentrationCCRF-CEM Human leukemic lymphoblast cell lineCOX-2 Cyclooxygenase-2CRC Colorectal cancer cell lineD6 chloroquine-sensitiveDCM DichloromethaneDNA Deoxyribonucleic acidDRC Democratic Republic of CongoENT36 chloroquine-resistantERK Extracellular signal-regulated kinaseGAP3 Glycosylation-associated proteinGI50 (50% growth inhibition)Glut1, Glut3 and Glut4 Glucose transporter genesK-562 Human chronic myeloid leukemia cell lineK67 chloroquine-resistantH37Ra Mycobacterium tuberculosisHCT-8 Human colon cancer cell lineHTC-15 Human colon cancer cell lineHeLa Human cervical cancer cell lineHELF Human embryonic lung fibroblastHepG2 (hepatocellular carcinoma) Liver cancer cell lineHk2 Hexokinase 2HIV Human Immunodeficiency VirusHSV Herpes simplex virusHT29 Human colon cancer cell lineIC12 Minimum concentration that gives an inhibition zone of 12 mm diameterIC50 Half-maximal inhibitory concentrationiNOS Inducible nitric oxide synthaseLdha Lactate dehydrogenase-ALPS LipopolysaccharidePharmaceuticals 2023, 16, 1390 25 of 28MCF7 human breast cancer cell lineMDA-MB-231 Epithelial, human breast cancer cell lineMDA-MB435 Epithelial, human breast cancer cell lineMIC Minimal inhibitory concentrationmRNA Messenger Ribonucleic acidNCI National Cancer InstituteNCI-H460 Non-small cell lung cancerNCI-H490 Lung cancer cell lineNO Nitric oxideNRF National Research FoundationPGE(2) Prostaglandin E(2)RAW 264.7 Mouse macrophage cell lineROS Reactive oxygen speciesSKBR3 Breast cancer cell lineSR Spontaneous remission leukemia cell lineSW620 Human colon cancer cell lineTGI Total growth inhibitionTK10 Renal cancerUACC62 Melanoma cell lineU937 Human leukemic cell lineW2 chloroquine-resistantWHO World Health Organisation\u00b5g/mL Micrograms per milliliter\u00b5mol/L Micromole per litre\u00b5g/spot Micrograms per spotReferences1. Plants of the World Online (Continuously Updated). Facilitated by the Royal Botanic Gardens, Kew. Available online: https://powo.science.kew.org/ (accessed on 11 August 2022).2. Radcliffe-Smith, A. Genera Euphorbiacearum; Royal Botanic Gardens, Kew: Richmond, UK, 2001.3. Radcliffe-Smith, A.; Hoffmann, P.; Ranaivojaona, R.; Ralimanan, A.H. Suregada celastroides Radcl.-Sm. & Petra Hoffm. (Euphor-biaceae), a new species from eastern Madagascar. Kew Bull. 2003, 58, 965\u2013970.4. Wurdack, K.J.; Hoffmann, P.; Chase, M.W. Molecular phylogenetic analysis of uniovulate Euphorbiaceae (Euphorbiaceae sensustricto) using plastid rbcL and trnL-F DNA sequences. Am. J. Bot. 2005, 92, 1397\u20131420. [CrossRef] [PubMed]5. L\u00e9onard, J. Notulae Systematicae XXIV. Note sur les genres Suregada Roxb. Ex Rottl. et Gelonium Roxb. Ex Willd. (Euphorbiaceae).Bull. Jard. Bot. L\u2019\u00e9tat Brux. 1958, 28, 443\u2013450. [CrossRef]6. Darbyshire, I.; Kordofani, M.; Farag, I. The Plants of Sudan and South Sudan: An Annotated Checklist; Royal Botanic Gardens, Kew:Richmond, UK, 2015.7. African Plant Database (Version 3.4.0). Conservatoire et Jardin Botaniques de la Ville de Gen\u00e8ve and South African NationalBiodiversity Institute, Pretoria. Available online: http://africanplantdatabase.ch (accessed on 20 August 2022).8. Govaerts, R.; Frodin, D.G.; Radcliffe-Smith, A. World Checklist and Bibliography of Euphorbiaceae (and Pandaceae) 1-4: 1-1622; TheBoard of Trustees of the Royal Botanic Gardens, Kew: Richmond, UK, 2000.9. Venkatesan, M.; Viswanathan, M.B.; Ramesh, N.; Lakshmanaperumalsamy, P. Antibacterial potential from Indian Suregadaangustifolia. J. Ethnopharmacol. 2005, 93, 349\u2013352. [CrossRef] [PubMed]10. Norscia, I.; Borgognini-Tarl, S.M. Ethnobotanical reputation of plant species from two forests of Madagascar: A preliminaryinvestigation. S. Afr. J. Bot. 2006, 72, 656\u2013660. [CrossRef]11. Razafindraibe, M.; Kuhlman, A.R.; Rabarison, H.; Rakotoarimanana, V.; Rajeriarison, C.; Rakotoarivelo, N.; Randrianarivony,T.; Rakotoarivony, F.; Ludovic, R.; Randrianasolo, A.; et al. Medicinal plants used by women from Agnalazaha littoral forest(Southeastern Madagascar). J. Ethnobiol. Ethnomedicine 2013, 9, 1\u201313. [CrossRef]12. Reddy, A.M.; Babu, M.V.S.; Rao, R.R. Ethnobotanical study of traditional herbal plants used by local people of SeshachalamBiosphere Reserve in Eastern Ghats, India. Herba Pol. 2019, 65, 40\u201354. [CrossRef]13. Pulladiah, T.; Krishnamurthy, K.V.; Bahadur, B. Ethnobotany of India, Volume 2: Western Ghats and West Coast of Peninsular India;Apple Academic Press, Inc.: Palm Bay, FL, USA, 2017; p. 184.14. Lovett, J.C.; Ruffo, C.K.; Gereau, R.E. Field Guide to the Moist Forest Trees of Tanzania; The Society for Environmental Exploration:London, UK, 2005; p. 97.15. Choudhary, M.I.; Gondal, H.Y.; Abbaskha, A.; Jahan, I.A.; Parvea, M.; Nahar, N.; Rahman, A.U. Revisiting diterpene lactones ofSuregada multiflora. Tetrahedron 2004, 60, 7933\u20137941. [CrossRef]16. Jahan, I.A.; Nahar, N.; Mosihuzzaman, M.; Shaheen, F.; Rahman, A.U.; Choudhary, M.I. Six new diterpenoids from Suregadamultiflora. J. Nat. Prod. 2004, 67, 1789\u20131795. [CrossRef]Pharmaceuticals 2023, 16, 1390 26 of 2817. Tewtrakul, S.; Subhadhirasakul, S.; Cheenpracha, S.; Yodsaoue, O.; Ponglimanont, C.; Karalai, C. Anti-inflammatory principles ofSuregada multiflora against nitric oxide and prostaglandin E2 releases. J. Ethnopharmacol. 2011, 133, 63\u201366. [CrossRef]18. Patil, A.S. Ethnomedicinal uses of some plants used by Gond tribe of Gadchiroli district, Maharashtra. Indian J. Nat. Prod. Resour.2016, 7, 56\u201362.19. Kumar, S.; Pandey, A.K.; Thakur, J.R. Plant extracts used as organic pesticides. J. Med. Plants Stud. 2017, 5, 117\u2013120.20. Pal, D.C.; Sharma, S.K.; Das, M.; Sahu, R.K. Evaluation of hepatoprotective and in vitro antioxidant activity of Suregada multiflora(Bark) in Swiss Albino mice. Int. J. Pharm. Sci. 2011, 3, 127\u2013130.21. Hartley, T.G. The ethnobotany of the Northern Cheyenne Indians of Montana. J. Ethnopharmacol. 2001, 74, 141\u2013156.22. Jamaluddin, M.D.; Sayeed, A.; Khaleque, M.A.; Uddin, M.J. Traditional use of medicinal plants in Bangladesh to treat urinarytract infections and sexually transmitted diseases. Ethnobot. Res. Appl. 2015, 14, 119\u2013133.23. Russof, L.L.; Dissanayake, M.D.M.S.; Amarasinghe, M.D.; Fonseka, D.M. Evaluation of selected forest tree species in the dry zoneof Sri Lanka for wood strength properties. J. Trop. For. Sci. 2003, 15, 483\u2013490.24. Fassil, A.; Gashaw, G. An ethnobotanical study of medicinal plants in chiro district, West Hararghe, Ethiopia. Afr. J. Plant Sci.2019, 13, 309\u2013323.25. Schmelzer, G.H.; Wageningen, A.G.F. Plant Resources of Tropical Africa; PROTA Foundation-Backhuys\u2014CTA PROTA: Wageningen,The Netherlands, 2008; Volume 11, p. 582.26. Runyoro, D.K.B.; Ngassapa, O.D.; Matee, M.I.N.; Joseph, C.C.; Moshi, M.J. Medicinal plants used by Tanzanian traditional healersin the management of Candida infections. J. Ethnopharmacol. 2006, 106, 158\u2013165. [CrossRef]27. Hedberg, I.; Hedberg, O.; Madati, P.J.; Mshigeni, K.E.; Mshiu, E.N.; Samuelsson, G. Inventory of plants used in traditionalmedicine in Tanzania. Part II. Plants of the families Dilleniaceae\u2013Opiliaceae. J. Ethnopharmacol. 1983, 9, 105\u2013127. [CrossRef]28. Watt, J.M.; Breyer-Brandwijk, M.G. The Medicinal and Poisonous Plants of Southern and Eastern Africa, 2nd ed.; E. & S. Livingstone:London, UK, 1962.29. Innocent, E.; Joseph, C.C.; Gikonyo, N.K.; Nkunya, M.H.; Hassanali, A. Constituents of the essential oil of Suregada zanzibariensisleaves are repellent to the mosquito, Anopheles gambiae s.s. J. Insect Sci. 2010, 2010, 10\u201357.30. Monaco Encyclopaedia Suregada multiflora; Monaco Nature Encyclopedia: Monte Carlo, Monaco, 2018.31. Useful Tropical Plants. Available online: www.theferns.info (accessed on 15 August 2023).32. Suregada lanceolata-South Indian Suregada. Available online: www.flowersofindia.net (accessed on 18 August 2023).33. Available online: https://casabio.org/taxa (accessed on 5 August 2023).34. Jahan, I.A.; Nahar, N.; Mosihuzzaman, M.; Shaheen, F.; Parween, Z.; Rahman, A.U.; Choudhary, M.I. Novel diterpene lactonesfrom Suregada multiflora. J. Nat. Prod. 2002, 65, 932\u2013934. [CrossRef] [PubMed]35. Lee, C.L.; Chang, F.R.; Hsieh, P.W.; Chiang, M.Y.; Wu, C.C.; Huang, Z.Y.; Lan, Y.H.; Chen, M.; Lee, K.H. Cytotoxic ent-abietanediterpenes from Gelonium aequoreum. Phytochemistry 2008, 69, 276\u2013287. [CrossRef] [PubMed]36. Cheenpracha, S.; Yodsoue, O.; Karalai, C.; Ponglimanont, C.; Subhadhirasakul, S.; Tewtrakul, S.; Kanjana-Opas, A. Potentialanti-allergic ent-kaurene diterpenes from the bark of Suregada multiflora. Phytochemistry 2006, 67, 2630\u20132634. [CrossRef] [PubMed]37. Gondal, H.Y.; Choudhary, M.I. New Diterpene Lactone from the leaves of Suregada multiflora. Chem. Nat. Compd. 2016, 52, 421\u2013423.[CrossRef]38. Hanson, J.R. Diterpenoids of terrestrial origin. Nat. Prod. Rep. 2015, 32, 1654\u20131663. [CrossRef] [PubMed]39. Vasas, A.; Hohmann, J. Euphorbia diterpenes: Isolation, structure, biological activity, and synthesis (2008\u20132012). Chem. Rev. 2014,114, 8579\u20138612. [CrossRef]40. Wu, Q.C.; Tang, Y.P.; Ding, A.W.; You, F.Q.; Zhang, L.; Duan, J.A. 13C-NMR data of three important diterpenes isolated fromEuphorbia species. Molecules 2009, 14, 4454\u20134475. [CrossRef]41. Dewick, M. Medicinal Natural Products: A Biosynthetic Approach, 3rd ed.; John Wiley & Sons, Ltd.: Chichester, UK, 2006; ISBN978-0-47074-168-9.42. Zhang, J.; He, J.; Wang, X.X.; Shi, Y.X.; Zhang, N.; Ma, B.Z.; Zhang, W.K.; Xu, J.K. Ent-abietane diterpenoids and their probablebiogenetic precursors from the roots of Euphorbia fischeriana. RSC Adv. 2017, 7, 55859\u201355865. [CrossRef]43. Sandjo, L.P.; Kuete, V. Diterpenoids from the Medicinal Plants of Africa. In Medicinal Plant Research in Africa; Elsevier: Amsterdam,The Netherlands, 2013; pp. 105\u2013121.44. Rubinger, M.M.M.; Castelo-Branco, P.d.A.; Guilardi, S.; Souza, E.M.R.; Gambardella, M.T.d.o.P.; Borges, E.E.L.; Ferreira-Alves, D.L.; Pilo-Veloso, D. Preparation, X-ray structural studies, and plant growth regulatory activity of methyl 6\u03b1,7\u03b2-thiocarbonyldioxyvouacapan-17\u03b2-oate. J. Braz. Chem. Soc. 2004, 15, 219\u2013223. [CrossRef]45. Sakan, F.; Iwashita, T.; Hamanaka, N. Structures of Metasequoic Acid A and B. Chem. Lett. 1988, 17, 123\u2013126. [CrossRef]46. Kalenga, T.M.; Mollel, J.T.; Said, J.; Orthaber, A.; Ward, J.S.; Atilaw, Y.; Umereweneza, D.; Ndoile, M.M.; Munissi, J.J.E.; Rissanen,K.; et al. Modified ent-Abietane ditepenoids from the leaves of Suregada zanzibariesis. J. Nat. Prod. 2022, 85, 2135\u20132141. [CrossRef][PubMed]47. Gondal, H.Y.; Nisar, M.; Choudhary, M.I. Antileishmanial activity of diterpene lactones from Suregada multiflora and theirsemisynthetic derivatives. Curr. Bioact. Compd. 2020, 16, 53\u201357. [CrossRef]48. Talapatra, S.K.; Das, G.; Talapatra, B. Stereostructures and molecular conformations of six diterpene lactones from Geloniummultiflorum. Phytochemistry 1989, 28, 1181\u20131185. [CrossRef]Pharmaceuticals 2023, 16, 1390 27 of 2849. Talapatra, B.; Das, G.; Das, A.K.; Biswas, K.; Talapatra, S.K. Stereostructures and conformations of four diterpene lactones fromGelonium multiflorum. Phytochemistry 1998, 49, 1353\u20131359. [CrossRef]50. Mangisa, M.; Tembu, V.J.; Fouche, G.; Nthambeleni, R.; Peter, X.; Langat, M.K. Ent-abietane diterpenoids from Suregadazanziberiensis Baill. (Euphorbiaceae), their cytotoxic and anticancer properties. Nat. Prod. Res. 2018, 33, 3240\u20133247. [CrossRef]51. He, S.L.; Yan, R.Y.; Zuo, L.; Chen, R.Y. Ent-Abietane and ent-Kaurane diterpenoids from the Roots of Suregada glomerulata. PlantaMed. 2009, 75, 641\u2013646. [CrossRef]52. Yan, R.Y.; Tan, Y.X.; Cui, X.Q.; Chen, R.; Yu, D.Q. Diterpenoids from the roots of Suregada glomerulata. J. Nat. Prod. 2008, 71,195\u2013198. [CrossRef]53. Yan, R.Y.; Wang, H.Q.; Lui, C.; Chen, R.Y.; Yu, D.Q. Three new water-soluble alkaloids from the leaves of Suregada glomerulata(Blume) Baill. Fitoterapia 2011, 82, 247\u2013250. [CrossRef]54. Sengupta, P.; Khastgir, H.N. Terpenoids, and related compounds-III: Bauerenol and multiflorenol from gelonium multiflorum A.Juss. The structure of multiflorenol. Tetrahedron 1963, 19, 123\u2013132. [CrossRef]55. Kite, G.C.; Hoffmann, P.; Lees, D.C.; Wurdack, K.J.; Gillespie, L.J. \u03b1-Homonojirimycin and other polyhydroxyalkaloids in SuregadaRoxb. ex Rottl. (Euphorbiaceae). Biochem. Syst. Ecol. 2005, 33, 1183\u20131186. [CrossRef]56. Gondal, H.Y. Isolation and Biotransformation of Some Bioactive Compounds from Medicinal Plants. Ph.D. Thesis, H.E.J. ResearchInstitute of Chemistry, International Center for Chemical Sciences, University of Karachi, Karachi, Pakistan, 2004; pp. 1\u20138.57. Parveen, N.; Khan, N.U. Luteolin 7, 4\u2032-dimethyl ether 3\u2032-glucoside from Gelonium multiflorum. Phytochemistry 1987, 26, 2130\u20132131.[CrossRef]58. Das, B.; Chakravarthy, A.K. Three flavone glycosides from gelonium multiflorum. Phytochemistry 1993, 33, 493\u2013496. [CrossRef]59. Yan, R.Y.; Wang, H.Q.; Kang, J.; Chen, R.Y. Pyrrolidine-type iminosugars from leaves of Suregada glomerulata. Carbohydr. Res. 2014,384, 9\u201312. [CrossRef]60. Khuntong, S.; Sudprasert, W. Extraction and basic testing for antibacterial activity of the chemical constituents in Suregadamultiflorum. Kasetsart J. Nat. Sci. 2008, 42, 429\u2013434.61. Islam, M.S.; Zahan, R.; Alam, M.B.; Nazn, M.; Sarkar, G.C.; Mosaddik, M.A.; Haque, M.E. Studies on antibacterial and insecticidalactivities of Suregada multiflora. LARCJI 2011, 2, 62\u201367.62. Valente, C.; Pedro, M.; Duarte, A.; Nascimento, M.S.J.; Abreu, P.M.; Ferreira, M.J. Bioactive diterpenoids, a new jatrophane andtwo ent-abietanes, and other constituents from Euphorbia pubescens. J. Nat. Prod. 2004, 67, 902\u2013904. [CrossRef] [PubMed]63. Kannathasan, K.; Senthilkumar, A.; Venkatesalu, V. Crystal structure and antibacterial evaluation of epifriedelinol isolated fromVitex peduncularis Wall. ex Schauer. Arab. J. Chem. 2019, 12, 2289\u20132292. [CrossRef]64. Lu, Z.Q.; Guan, S.H.; Li, X.N.; Chen, G.T.; Zhang, J.Q.; Huang, H.L.; Liu, X.; Guo, D.A. Cytotoxic diterpenes from Euphorbiahelioscopia. J. Nat. Prod. 2008, 71, 873\u2013876. [CrossRef]65. Wang, Y.; Yu, X.; Wang, L.; Zhang, F.; Zhang, Y. Research Progress on Chemical Constituents and Anticancer PharmacologicalActivities of Euphorbia lunulata Bunge. BioMed Res. Int. 2020, 2020, 3618941. [CrossRef]66. Wang, J.H.; Zhou, Y.J.; Bai, X.; He, P. Jolkinolide B from Euphorbia fischeriana Steud induces apoptosis in human leukemic U937cells through PI3K/Akt and XIAP pathways. Mol. Cell. 2011, 32, 451\u2013457. [CrossRef]67. Gao, C.; Yan, X.; Wang, B. Jolkinolide B induces apoptosis and inhibits tumor growth in mouse melanoma B16F10 cells by alteringglycolysis. Sci. Rep. 2016, 6, 36114. [CrossRef] [PubMed]68. Sun, C.; Cui, H.; Yang, H.; Du, X.; Yue, L.; Liu, J.; Lin, Y. Anti-metastatic effect of jolkinolide B and the mechanism of activity inbreast cancer MDA-MB-231 cells. Oncol. Lett. 2015, 10, 1117\u20131122. [CrossRef] [PubMed]69. Chen, Y.; Peng, J.; Cao, S. Bauerenol inhibits proliferation, migration, and invasion of retinoblastoma cells via induction ofapoptosis, autophagy, and cell cycle arrest. Trop. J. Pharm. Res. 2022, 21, 1377\u20131382. [CrossRef]70. Luo, H.; Wang, A. Induction of apoptosis in K562 cells by jolkinolide B. Can. J. Physiol. Pharmacol. 2006, 84, 959\u2013965. [CrossRef]71. Aljamali, N.M.; Al-zubaidy, Z.H.; Enad, A.H. Bacterial infection and common bacterial diseases: A Review. Pharm. Nanotechnol.2021, 3, 13\u201323.72. Kuroshima, K.N.; Campos-Buzzi, F.; Yunes, R.A.; Monache, F.D.; Filho, V.C. Chemical composition and antinociceptive propertiesof Hyeronima alchorneoides. Leaves. Pharm. Biol. 2005, 43, 573\u2013578. [CrossRef]73. Bourinbaiar, A.S.; Lee-Huang, S. The activity of plant-derived antiretroviral proteins MAP30 and GAP31 against herpes simplexvirus infection in vitro. Biochem. Biophys. Res. Commun. 1996, 219, 923\u2013929. [CrossRef]74. Kigondua, E.V.M.; Rukunga, G.M.; Keriko, J.M.; Tonui, W.K.; Gathirwa, J.W.; Kirira, P.G.; Irungu, B.; Ingonga, J.M.; Ndiege,I.O. Anti-parasitic activity and cytotoxicity of selected medicinal plants from Kenya. J. Ethnopharmacol. 2009, 123, 504\u201350963.[CrossRef]75. Kumar, S.P.; Viswanathan, M.B.G.; Venkatesan, M.; Balakrishna, K. Bauerenol, a triterpenoid from Indian Suregada angustifolia:Induces reactive oxygen species-mediated P38MAPK activation and apoptosis in human hepatocellular carcinoma (HepG2) cells.Tumor Biol. 2017, 39, 1010428317698387.76. Muhammad, I.; Midiwo, J.; Tekwani, B.L.; Samoylenko, V.; Sahu, R.; Machumi, F.; Rahman, A.A.; Walker, L.A.; Hester, J.P.Antileishmanial Activity of Kenyan Medicinal Plants; University of Nairobi: Nairobi, Kenya, 2008; pp. 1\u20132.Pharmaceuticals 2023, 16, 1390 28 of 2877. Omulokoli, E.; Khan, B.; Chhabra, S.C. Antiplasmodial activity of four Kenyan medicinal plants. J. Ethnopharmacol. 1997, 56,133\u2013137. [CrossRef]78. Mohana, D.C.; Raveesha, K.A. Antibacterial activity of Caesalpinia coriaria (Jacq.) Willd. against plant pathogenic Xanthomonaspathovars: An eco-friendly approach. JAST 2006, 2, 317\u2013327.Disclaimer/Publisher\u2019s Note: The statements, opinions and data contained in all publications are solely those of the individualauthor(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury topeople or property resulting from any ideas, methods, instructions or products referred to in the content."}